| Utestående aktier | 77,105,799 shares |
| Insideraktier | 1 060 395 shares |
| Insynsägande | 1,38 % |
| Totalt antal insynspersoner | 38 |
Insider Sentiment Score
Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.
Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.
Uppdateringsfrekvens: Dagligen
Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.
Office Sentiment Score
Officersentiment Score hittar företag som köps av Corporate Officers.
Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.
Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.
Uppdateringsfrekvens: Dagligen
Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.
Viktiga insidernyckeltal
Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.
Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).
Procent av flytande köpta av insiders (ranking)
0.000 %( )
5102 out of 11219Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.
Insiderhandelsdiagram
Xenon Pharmaceuticals Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.
Insiderlista och lönsamhetsstatistik
Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.
See our leaderboard of most profitable insider traders.
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Sherry Aulin Chief Financial Officer - [O] | 0 | 0 | |
| Ernesto Aycardi-fonseca Chief Medical Officer - [O] | 0 | 0 | |
| Mohammad Azab Director - [D] | 74 225 | 74 225 | |
| Biotechnology Value Fund Ii Lp - | 59 464 | 59 464 | |
| Biotechnology Value Fund L P - | 59 464 | 59 464 | |
|
Bvf Inc/il
10% Owner -
|
59 464 | 59 464 | |
|
Bvf Partners L P/il
10% Owner -
|
59 464 | 59 464 | |
| BVF Partners OS Ltd. - | 59 464 | 59 464 | |
| Biotechnology Value Trading Fund OS LP - | 59 464 | 59 464 | |
| Gary Bridger | 5 144 | ||
| Cohen Charles J. VP, Biology - [O] | 6 550 | 6 550 | |
| Corraini Karen G. See Remarks - [O] | 4 114 | 4 114 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Gillian Cannon Director - [D] | 0 | 0 | |
| Darren S Cline Chief Commercial Officer - [O] | 0 | 0 | |
| Clarissa Desjardins Director - [D] | 0 | 0 | |
| Andrea DiFabio Chief Legal Officer - [O] | 0 | 0 | |
| Empfield James R. EVP, Drug Discovery - [O] | 10 000 | 10 000 | |
| Johnston L Evans Director - [D] | 444 655 | 444 655 | |
| Steven Gannon Director - [D] | 7 141 | 7 141 | |
| Garofalo Elizabeth A. Director - [D] | 0 | 0 | |
| Goldberg Y. Paul VP of Clinical Development - [O] | 6 000 | 6 000 | |
| Gover Justin D. Director - [D] | 0 | 0 | |
| Frank A Holler Director - [D] | 143 653 | 143 653 | |
| Michael R Hayden Director - [D] | 116 206 | 116 206 | |
| Christopher John Kenney Chief Medical Officer - [O] | 0 | 0 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
|
Mark N Lampert
10% Owner -
|
59 464 | 59 464 | |
| Ian Mortimer PRESIDENT & CEO, Director - [D] [O] | 31 302 | 31 302 | |
|
Associates, LLP MX
10% Owner -
|
0 | 0 | |
| Patrick Machado Director - [D] | 0 | 0 | |
| Gary Patou Director - [D] | 23 573 | 23 573 | |
| Pimstone Simon N. Director - [D] | 6 000 | 6 000 | |
| Sherrington Robin EVP, Strategy & Innovation - [O] | 8 398 | 8 398 | |
| Richard H Scheller Director - [D] | 7 000 | 7 000 | |
| Stein Evan A. Director - [D] | 4 172 | 4 172 | |
| Dawn Svoronos Director - [D] | 25 000 | 25 000 | |
| Michael M Tarnow Director - [D] | 77 942 | 77 942 | |
| Seggern Christopher Von Chief Commercial Officer - [O] | 4 000 | 4 000 | |
| Raymond Winquist Head, Translational Research - [O] | 1 000 | 1 000 |
Report errors via our new Insider Auditing Tool
Track Records av insiderköp - Kortsiktig vinstanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i XENE / Xenon Pharmaceuticals Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Track Records av insiderförsäljning - Kortsiktig förlustanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i XENE / Xenon Pharmaceuticals Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Transaktionshistorik
Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.
| Fil datum |
Handel datum |
Schema | Insider | Ticker | Värdepappertitel | Kod | Direkta | Utövningspris | Enhet pris |
Enheter ändrad |
Värde ändrad (1K) |
Kvarvarande Optioner |
Kvarvarande Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-24 | 3 | Cline Darren S | XENE | No securities are beneficially owned. | D | 0 | ||||||||
| 2025-06-06 | 2025-06-05 | 4 | GANNON STEVEN | XENE | Common Shares | D | 30,4800 | −3 | −0 | 7 141 | ||||
| 2025-05-16 | 2025-05-14 | 4 | GANNON STEVEN | XENE | Common Shares | D | 12,5700 | 5 144 | 65 | 7 144 | ||||
| 2025-01-27 | 2025-01-27 | 4 | MORTIMER IAN | XENE | Common Shares | D | 41,0700 | −1 149 | −47 | 31 302 | ||||
| 2025-01-27 | 2025-01-27 | 4 | MORTIMER IAN | XENE | Common Shares | D | 17,7600 | 1 149 | 20 | 32 451 | ||||
| 2025-01-27 | 2025-01-27 | 4 | MORTIMER IAN | XENE | Common Shares | D | 40,4600 | −15 166 | −614 | 31 302 | ||||
| 2025-01-27 | 2025-01-27 | 4 | MORTIMER IAN | XENE | Common Shares | D | 17,7600 | 15 166 | 269 | 46 468 | ||||
| 2025-01-27 | 2025-01-24 | 4 | MORTIMER IAN | XENE | Common Shares | D | 40,2000 | −22 468 | −903 | 31 302 | ||||
| 2025-01-27 | 2025-01-24 | 4 | MORTIMER IAN | XENE | Common Shares | D | 17,7600 | 22 468 | 399 | 53 770 | ||||
| 2025-01-27 | 2025-01-23 | 4 | MORTIMER IAN | XENE | Common Shares | D | 40,0800 | −16 217 | −650 | 31 302 | ||||
| 2025-01-27 | 2025-01-23 | 4 | MORTIMER IAN | XENE | Common Shares | D | 17,7600 | 16 217 | 288 | 47 519 | ||||
| 2024-12-19 | 2024-12-18 | 4 | AULIN SHERRY | XENE | Common Shares | D | 41,1900 | −11 510 | −474 | 0 | ||||
| 2024-12-19 | 2024-12-18 | 4 | AULIN SHERRY | XENE | Common Shares | D | 41,2800 | −4 490 | −185 | 11 510 | ||||
| 2024-12-19 | 2024-12-18 | 4 | AULIN SHERRY | XENE | Common Shares | D | 11,5800 | 16 000 | 185 | 16 000 | ||||
| 2024-12-19 | 2024-12-18 | 4 | AULIN SHERRY | XENE | Common Shares | D | 41,2300 | −7 199 | −297 | 0 | ||||
| 2024-12-19 | 2024-12-18 | 4 | AULIN SHERRY | XENE | Common Shares | D | 41,2800 | −2 135 | −88 | 7 199 | ||||
| 2024-12-19 | 2024-12-18 | 4 | AULIN SHERRY | XENE | Common Shares | D | 9,4400 | 9 334 | 88 | 9 334 | ||||
| 2024-11-22 | 2024-11-22 | 4 | PATOU GARY | XENE | Common Shares | D | 41,0500 | −2 040 | −84 | 23 573 | ||||
| 2024-11-22 | 2024-11-22 | 4 | PATOU GARY | XENE | Common Shares | D | 39,8000 | −1 046 | −42 | 25 613 | ||||
| 2024-11-22 | 2024-11-22 | 4 | PATOU GARY | XENE | Common Shares | D | 13,4800 | 3 086 | 42 | 26 659 | ||||
| 2024-11-22 | 2024-11-22 | 4 | PATOU GARY | XENE | Common Shares | D | 41,1100 | −2 851 | −117 | 23 573 | ||||
| 2024-11-22 | 2024-11-22 | 4 | PATOU GARY | XENE | Common Shares | D | 39,8000 | −649 | −26 | 26 424 | ||||
| 2024-11-22 | 2024-11-22 | 4 | PATOU GARY | XENE | Common Shares | D | 7,3800 | 3 500 | 26 | 27 073 | ||||
| 2024-03-11 | 2024-03-08 | 4 | GAROFALO ELIZABETH A. | XENE | Common Shares | D | 45,6900 | −2 092 | −96 | 0 | ||||
| 2024-03-11 | 2024-03-08 | 4 | GAROFALO ELIZABETH A. | XENE | Common Shares | D | 46,1600 | −1 408 | −65 | 2 092 | ||||
| 2024-03-11 | 2024-03-08 | 4 | GAROFALO ELIZABETH A. | XENE | Common Shares | D | 18,5600 | 3 500 | 65 | 3 500 | ||||
| 2024-03-08 | 2024-03-07 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 46,3000 | −6 118 | −283 | 8 398 | ||||
| 2024-03-08 | 2024-03-07 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 46,1500 | −1 019 | −47 | 14 516 | ||||
| 2024-03-08 | 2024-03-07 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 45,9600 | −1 289 | −59 | 15 535 | ||||
| 2024-03-08 | 2024-03-07 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 9,8500 | 7 407 | 73 | 16 824 | ||||
| 2024-03-08 | 2024-03-07 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 45,9600 | −215 | −10 | 9 417 | ||||
| 2024-03-08 | 2024-03-07 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 9,8500 | 1 234 | 12 | 9 632 | ||||
| 2024-03-08 | 2024-03-07 | 4 | GANNON STEVEN | XENE | Common Shares | D | 46,2012 | −2 000 | −92 | 2 000 | ||||
| 2024-03-08 | 2024-03-07 | 4 | GANNON STEVEN | XENE | Common Shares | D | 46,3025 | −5 000 | −232 | 4 000 | ||||
| 2024-03-08 | 2024-03-07 | 4 | GANNON STEVEN | XENE | Common Shares | D | 46,2500 | −5 000 | −231 | 9 000 | ||||
| 2024-03-08 | 2024-03-07 | 4 | GANNON STEVEN | XENE | Common Shares | D | 46,4500 | −1 000 | −46 | 14 000 | ||||
| 2024-01-02 | 2023-12-29 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | −8 398 | 8 398 | ||||||
| 2023-12-20 | 2023-12-19 | 4 | AZAB MOHAMMAD | XENE | Common Shares | D | 9,8500 | 3 497 | 34 | 74 225 | ||||
| 2023-12-20 | 2023-12-19 | 4 | AZAB MOHAMMAD | XENE | Common Shares | D | 9,8500 | 823 | 8 | 70 728 | ||||
| 2023-12-15 | 2023-12-14 | 4/A | PATOU GARY See Note | XENE | Common Shares | I | 41,0500 | −7 598 | −312 | 4 902 | ||||
| 2023-12-15 | 2023-12-13 | 4 | PATOU GARY See Note | XENE | Common Shares | I | 41,0500 | −7 598 | −312 | 4 902 | ||||
| 2023-12-15 | 2023-12-13 | 4 | PATOU GARY | XENE | Common Shares | D | 39,8400 | −3 977 | −158 | 23 573 | ||||
| 2023-12-15 | 2023-12-13 | 4 | PATOU GARY | XENE | Common Shares | D | 39,6800 | −1 167 | −46 | 27 550 | ||||
| 2023-12-15 | 2023-12-13 | 4 | PATOU GARY | XENE | Common Shares | D | 9,0000 | 5 144 | 46 | 28 717 | ||||
| 2023-12-15 | 2023-12-13 | 4 | PATOU GARY | XENE | Common Shares | D | 39,1000 | −2 303 | −90 | 23 573 | ||||
| 2023-12-15 | 2023-12-13 | 4 | PATOU GARY | XENE | Common Shares | D | 39,6800 | −577 | −23 | 25 876 | ||||
| 2023-12-15 | 2023-12-13 | 4 | PATOU GARY | XENE | Common Shares | D | 9,8500 | 2 880 | 28 | 26 453 | ||||
| 2023-12-15 | 2023-12-13 | 4 | PATOU GARY | XENE | Common Shares | D | 38,9400 | −5 100 | −199 | 23 573 | ||||
| 2023-12-15 | 2023-12-13 | 4 | PATOU GARY | XENE | Common Shares | D | 39,6800 | −1 278 | −51 | 28 673 | ||||
| 2023-12-15 | 2023-12-13 | 4 | PATOU GARY | XENE | Common Shares | D | 9,8500 | 6 378 | 63 | 29 951 | ||||
| 2023-08-24 | 2023-08-24 | 4 | Svoronos Dawn | XENE | Common Shares | D | 38,7000 | −25 000 | −968 | 25 000 | ||||
| 2023-08-10 | 3 | Gover Justin D. | XENE | No securities are beneficially owned. | D | 0 | ||||||||
| 2023-08-10 | 3 | Cannon Gillian | XENE | No securities are beneficially owned. | D | 0 | ||||||||
| 2023-06-01 | 2023-06-01 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 38,7800 | −24 255 | −941 | 6 000 | ||||
| 2023-06-01 | 2023-06-01 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 38,5300 | −20 745 | −799 | 30 255 | ||||
| 2023-06-01 | 2023-06-01 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 17,7600 | 45 000 | 799 | 51 000 | ||||
| 2023-06-01 | 2023-06-01 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 38,9700 | −7 458 | −291 | 6 000 | ||||
| 2023-06-01 | 2023-06-01 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 38,5300 | −1 860 | −72 | 13 458 | ||||
| 2023-06-01 | 2023-06-01 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 7,6900 | 9 318 | 72 | 15 318 | ||||
| 2023-06-01 | 2023-05-31 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 38,6900 | −26 856 | −1 039 | 6 000 | ||||
| 2023-06-01 | 2023-05-31 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 38,3700 | −23 144 | −888 | 32 856 | ||||
| 2023-06-01 | 2023-05-31 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 17,7600 | 50 000 | 888 | 56 000 | ||||
| 2023-06-01 | 2023-05-31 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 38,8100 | −23 670 | −919 | 6 000 | ||||
| 2023-06-01 | 2023-05-31 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 38,3700 | −6 165 | −237 | 29 670 | ||||
| 2023-06-01 | 2023-05-31 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 9,8500 | 29 835 | 294 | 35 835 | ||||
| 2023-06-01 | 2023-05-31 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 38,5300 | −12 000 | −462 | 6 000 | ||||
| 2023-06-01 | 2023-05-30 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 39,9000 | −19 000 | −758 | 18 000 | ||||
| 2023-06-01 | 2023-05-30 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 38,6300 | −18 006 | −696 | 37 000 | ||||
| 2023-05-26 | 2023-05-24 | 4 | MORTIMER IAN | XENE | Common Shares | D | 41,4900 | −1 407 | −58 | 31 302 | ||||
| 2023-05-26 | 2023-05-24 | 4 | MORTIMER IAN | XENE | Common Shares | D | 41,8400 | −1 171 | −49 | 32 709 | ||||
| 2023-05-26 | 2023-05-24 | 4 | MORTIMER IAN | XENE | Common Shares | D | 9,8500 | 6 172 | 61 | 33 880 | ||||
| 2023-05-26 | 2023-05-24 | 4 | MORTIMER IAN | XENE | Common Shares | D | 41,3700 | −13 179 | −545 | 27 708 | ||||
| 2023-05-26 | 2023-05-24 | 4 | MORTIMER IAN | XENE | Common Shares | D | 41,8400 | −3 902 | −163 | 40 887 | ||||
| 2023-05-26 | 2023-05-24 | 4 | MORTIMER IAN | XENE | Common Shares | D | 9,8500 | 20 576 | 203 | 44 789 | ||||
| 2023-05-26 | 2023-05-24 | 4 | MORTIMER IAN | XENE | Common Shares | D | 41,4400 | −17 069 | −707 | 24 213 | ||||
| 2023-05-26 | 2023-05-24 | 4 | MORTIMER IAN | XENE | Common Shares | D | 41,8400 | −7 310 | −306 | 41 282 | ||||
| 2023-05-26 | 2023-05-24 | 4 | MORTIMER IAN | XENE | Common Shares | D | 9,4400 | 42 592 | 402 | 48 592 | ||||
| 2023-03-24 | 2023-03-24 | 4 | KENNEY CHRISTOPHER JOHN | XENE | Common Shares | D | 35,0100 | −700 | −25 | 0 | ||||
| 2023-03-09 | 2023-03-07 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 36,9400 | −8 242 | −304 | 55 006 | ||||
| 2023-03-09 | 2023-03-07 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 37,1300 | −1 618 | −60 | 63 248 | ||||
| 2023-03-09 | 2023-03-07 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 2,5900 | 30 864 | 80 | 64 866 | ||||
| 2023-03-09 | 2023-03-07 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 37,0100 | −10 990 | −407 | 34 002 | ||||
| 2023-03-09 | 2023-03-07 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 37,1300 | −2 160 | −80 | 44 992 | ||||
| 2023-03-09 | 2023-03-07 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 2,6800 | 41 152 | 110 | 47 152 | ||||
| 2022-12-13 | 2022-12-12 | 4 | AZAB MOHAMMAD | XENE | Common Shares | D | 2,6800 | 3 086 | 8 | 69 905 | ||||
| 2022-11-28 | 2022-11-25 | 4 | PATOU GARY | XENE | Common Shares | D | 34,7911 | −1 937 | −67 | 23 573 | ||||
| 2022-11-28 | 2022-11-25 | 4 | PATOU GARY | XENE | Common Shares | D | 34,3700 | −120 | −4 | 25 510 | ||||
| 2022-11-28 | 2022-11-25 | 4 | PATOU GARY | XENE | Common Shares | D | 2,6800 | 2 057 | 6 | 25 630 | ||||
| 2022-11-28 | 2022-11-23 | 4 | PATOU GARY | XENE | Common Shares | D | 34,3265 | −2 057 | −71 | 23 573 | ||||
| 2022-11-09 | 3 | DiFabio Andrea | XENE | No securities are beneficially owned. | D | 0 | ||||||||
| 2022-09-07 | 2022-09-02 | 4 | AULIN SHERRY | XENE | Common Shares | D | 39,5700 | −15 355 | −608 | 0 | ||||
| 2022-09-07 | 2022-09-02 | 4 | AULIN SHERRY | XENE | Common Shares | D | 39,5300 | −3 293 | −130 | 15 355 | ||||
| 2022-09-07 | 2022-09-02 | 4 | AULIN SHERRY | XENE | Common Shares | D | 4,7500 | 6 511 | 31 | 18 648 | ||||
| 2022-09-07 | 2022-09-02 | 4 | AULIN SHERRY | XENE | Common Shares | D | 3,1000 | 2 292 | 7 | 12 137 | ||||
| 2022-09-07 | 2022-09-02 | 4 | AULIN SHERRY | XENE | Common Shares | D | 8,4000 | 813 | 7 | 9 845 | ||||
| 2022-09-07 | 2022-09-02 | 4 | AULIN SHERRY | XENE | Common Shares | D | 7,4900 | 32 | 0 | 9 032 | ||||
| 2022-09-07 | 2022-09-02 | 4 | AULIN SHERRY | XENE | Common Shares | D | 9,4400 | 9 000 | 85 | 9 000 | ||||
| 2022-09-02 | 2022-09-01 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 38,8000 | −8 776 | −341 | 16 796 | ||||
| 2022-09-02 | 2022-09-01 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 38,0300 | −35 103 | −1 335 | 25 572 | ||||
| 2022-09-02 | 2022-09-01 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 38,8100 | −6 121 | −238 | 60 675 | ||||
| 2022-09-02 | 2022-09-01 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 4,7500 | 50 000 | 238 | 66 796 | ||||
| 2022-09-02 | 2022-08-31 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 38,5700 | −21 352 | −824 | 16 796 | ||||
| 2022-09-02 | 2022-08-31 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 37,8600 | −1 572 | −60 | 38 148 | ||||
| 2022-09-02 | 2022-08-31 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 4,7500 | 5 000 | 24 | 39 720 | ||||
| 2022-09-02 | 2022-08-31 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 2,6700 | 17 488 | 47 | 34 720 | ||||
| 2022-08-16 | 2022-08-12 | 4 | EMPFIELD JAMES R. | XENE | Common Shares | D | 38,6800 | −21 875 | −846 | 10 000 | ||||
| 2022-08-16 | 2022-08-12 | 4 | EMPFIELD JAMES R. | XENE | Common Shares | D | 38,0800 | −35 868 | −1 366 | 31 875 | ||||
| 2022-08-16 | 2022-08-12 | 4 | EMPFIELD JAMES R. | XENE | Common Shares | D | 38,0200 | −7 257 | −276 | 67 743 | ||||
| 2022-08-16 | 2022-08-12 | 4 | EMPFIELD JAMES R. | XENE | Common Shares | D | 4,7500 | 45 000 | 214 | 75 000 | ||||
| 2022-08-16 | 2022-08-12 | 4 | EMPFIELD JAMES R. | XENE | Common Shares | D | 3,1000 | 20 000 | 62 | 30 000 | ||||
| 2022-08-16 | 2022-08-16 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 38,8700 | −20 000 | −777 | 6 000 | ||||
| 2022-08-16 | 2022-08-16 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 38,2900 | −32 058 | −1 228 | 26 000 | ||||
| 2022-08-16 | 2022-08-15 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 37,7600 | −33 942 | −1 282 | 58 058 | ||||
| 2022-08-16 | 2022-08-12 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 39,1500 | −1 000 | −39 | 92 000 | ||||
| 2022-08-16 | 2022-08-12 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 38,6000 | −47 000 | −1 814 | 93 000 | ||||
| 2022-08-16 | 2022-08-12 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 37,9100 | −43 135 | −1 635 | 140 000 | ||||
| 2022-03-14 | 2022-03-10 | 4 | Von Seggern Christopher | XENE | Stock Option (Right to Buy) | D | 30,01 | 100 000 | 100 000 | |||||
| 2022-03-14 | 2022-03-10 | 4 | ROBIN SHERRINGTON | XENE | Stock Option (Right to Buy) | D | 30,01 | 75 000 | 75 000 | |||||
| 2022-03-14 | 2022-03-10 | 4 | PIMSTONE SIMON N. | XENE | Stock Option (Right to Buy) | D | 30,01 | 25 000 | 25 000 | |||||
| 2022-03-14 | 2022-03-10 | 4 | MORTIMER IAN | XENE | Stock Option (Right to Buy) | D | 30,01 | 400 000 | 400 000 | |||||
| 2022-03-14 | 2022-03-10 | 4 | KENNEY CHRISTOPHER JOHN | XENE | Stock Option (Right to Buy) | D | 30,01 | 125 000 | 125 000 | |||||
| 2022-03-14 | 2022-03-10 | 4 | AULIN SHERRY | XENE | Stock Option (Right to Buy) | D | 30,01 | 125 000 | 125 000 | |||||
| 2022-03-14 | 2022-03-10 | 4 | EMPFIELD JAMES R. | XENE | Stock Option (Right to Buy) | D | 30,01 | 65 000 | 65 000 | |||||
| 2022-03-08 | 2022-03-08 | 4/A | PIMSTONE SIMON N. | XENE | Common Shares | D | 30,8000 | −2 500 | −77 | 193 135 | ||||
| 2022-03-08 | 2022-03-08 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 30,5000 | −2 500 | −76 | 183 135 | ||||
| 2022-03-08 | 2022-03-08 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 30,5500 | −2 500 | −76 | 185 635 | ||||
| 2022-03-08 | 2022-03-08 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 30,2000 | −2 500 | −76 | 188 135 | ||||
| 2022-03-08 | 2022-03-08 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 30,1000 | −2 500 | −75 | 190 635 | ||||
| 2022-03-08 | 2022-03-08 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 3,8000 | −2 500 | −10 | 193 135 | ||||
| 2022-03-08 | 2022-03-08 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 30,6000 | −2 051 | −63 | 195 635 | ||||
| 2022-03-08 | 2022-03-07 | 4 | PIMSTONE SIMON N. | XENE | Stock Option (Right to Buy) | D | 3,67 | −20 576 | 0 | |||||
| 2022-03-08 | 2022-03-07 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 30,5500 | −2 500 | −76 | 197 686 | ||||
| 2022-03-08 | 2022-03-07 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 30,5000 | −7 500 | −229 | 200 186 | ||||
| 2022-03-08 | 2022-03-07 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 30,5200 | −2 500 | −76 | 207 686 | ||||
| 2022-03-08 | 2022-03-07 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 30,4400 | −4 516 | −137 | 210 186 | ||||
| 2022-03-08 | 2022-03-07 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 30,4500 | −4 516 | −138 | 214 702 | ||||
| 2022-03-08 | 2022-03-07 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 30,4900 | −4 517 | −138 | 219 218 | ||||
| 2022-03-08 | 2022-03-07 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 30,6000 | −5 037 | −154 | 223 735 | ||||
| 2022-03-08 | 2022-03-07 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 30,2300 | −1 990 | −60 | 228 772 | ||||
| 2022-03-08 | 2022-03-07 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 3,6700 | 20 576 | 76 | 230 762 | ||||
| 2022-03-08 | 2022-03-04 | 4 | PIMSTONE SIMON N. | XENE | Stock Option (Right to Buy) | D | 3,67 | −10 288 | 0 | |||||
| 2022-03-08 | 2022-03-04 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 30,5600 | −4 793 | −146 | 210 186 | ||||
| 2022-03-08 | 2022-03-04 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 30,6600 | −4 532 | −139 | 214 979 | ||||
| 2022-03-08 | 2022-03-04 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 31,4200 | −963 | −30 | 219 511 | ||||
| 2022-03-08 | 2022-03-04 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 3,6700 | 10 288 | 38 | 220 474 | ||||
| 2022-03-08 | 2022-03-04 | 4 | ROBIN SHERRINGTON | XENE | Stock Option (Right to Buy) | D | 3,67 | −6 172 | 0 | |||||
| 2022-03-08 | 2022-03-04 | 4 | ROBIN SHERRINGTON | XENE | Stock Option (Right to Buy) | D | 3,67 | −1 234 | 0 | |||||
| 2022-03-08 | 2022-03-04 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 30,2300 | −5 000 | −151 | 17 232 | ||||
| 2022-03-08 | 2022-03-04 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 31,0500 | −5 000 | −155 | 22 232 | ||||
| 2022-03-08 | 2022-03-04 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 30,1500 | −5 000 | −151 | 27 232 | ||||
| 2022-03-08 | 2022-03-04 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 30,5600 | −6 710 | −205 | 32 232 | ||||
| 2022-03-08 | 2022-03-04 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 3,6700 | 6 172 | 23 | 38 942 | ||||
| 2022-03-08 | 2022-03-04 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 31,4200 | −696 | −22 | 32 770 | ||||
| 2022-03-08 | 2022-03-04 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 3,6700 | 1 234 | 5 | 33 466 | ||||
| 2022-03-08 | 2022-03-07 | 4 | EMPFIELD JAMES R. | XENE | Stock Option (Right to Buy) | D | 6,76 | −40 000 | 0 | |||||
| 2022-03-08 | 2022-03-07 | 4 | EMPFIELD JAMES R. | XENE | Stock Option (Right to Buy) | D | 8,40 | −2 500 | 0 | |||||
| 2022-03-08 | 2022-03-07 | 4 | EMPFIELD JAMES R. | XENE | Common Shares | D | 30,5400 | −31 048 | −948 | 10 000 | ||||
| 2022-03-08 | 2022-03-07 | 4 | EMPFIELD JAMES R. | XENE | Common Shares | D | 30,6200 | −1 805 | −55 | 41 048 | ||||
| 2022-03-08 | 2022-03-07 | 4 | EMPFIELD JAMES R. | XENE | Common Shares | D | 30,2300 | −8 952 | −271 | 42 853 | ||||
| 2022-03-08 | 2022-03-07 | 4 | EMPFIELD JAMES R. | XENE | Common Shares | D | 6,7600 | 40 000 | 270 | 51 805 | ||||
| 2022-03-08 | 2022-03-07 | 4 | EMPFIELD JAMES R. | XENE | Common Shares | D | 30,2300 | −695 | −21 | 11 805 | ||||
| 2022-03-08 | 2022-03-07 | 4 | EMPFIELD JAMES R. | XENE | Common Shares | D | 8,4000 | 2 500 | 21 | 12 500 | ||||
| 2022-03-08 | 2022-03-04 | 4 | EMPFIELD JAMES R. | XENE | Stock Option (Right to Buy) | D | 8,40 | −25 000 | 0 | |||||
| 2022-03-08 | 2022-03-04 | 4 | EMPFIELD JAMES R. | XENE | Common Shares | D | 30,7900 | −18 315 | −564 | 10 000 | ||||
| 2022-03-08 | 2022-03-04 | 4 | EMPFIELD JAMES R. | XENE | Common Shares | D | 31,4200 | −6 685 | −210 | 28 315 | ||||
| 2022-03-08 | 2022-03-04 | 4 | EMPFIELD JAMES R. | XENE | Common Shares | D | 8,4000 | 25 000 | 210 | 35 000 | ||||
| 2022-01-21 | 2022-01-21 | 4 | KENNEY CHRISTOPHER JOHN | XENE | Common Shares | D | 28,8100 | 700 | 20 | 700 | ||||
| 2021-12-17 | 2021-12-15 | 4 | AZAB MOHAMMAD | XENE | Stock Option (Right to Buy) | D | 3,67 | −3 086 | 0 | |||||
| 2021-12-17 | 2021-12-15 | 4 | AZAB MOHAMMAD | XENE | Common Shares | D | 3,6700 | 3 086 | 11 | 66 819 | ||||
| 2021-12-10 | 2021-12-08 | 4 | PATOU GARY | XENE | Stock Option (Right to Buy) | D | 3,67 | −2 057 | 0 | |||||
| 2021-12-10 | 2021-12-08 | 4 | PATOU GARY | XENE | Common Shares | D | 3,6700 | 2 057 | 8 | 25 630 | ||||
| 2021-12-07 | 2021-12-06 | 4 | Von Seggern Christopher | XENE | Common Shares | D | 24,4000 | 4 000 | 98 | 4 000 | ||||
| 2021-11-16 | 2021-11-15 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 31,3300 | −17 557 | −550 | 210 186 | ||||
| 2021-08-25 | 3 | KENNEY CHRISTOPHER JOHN | XENE | No securities are beneficially owned. | D | 0 | ||||||||
| 2021-08-25 | 2021-08-23 | 4 | KENNEY CHRISTOPHER JOHN | XENE | Stock Option (Right to Buy) | D | 16,64 | 150 000 | 150 000 | |||||
| 2021-06-04 | 2021-06-03 | 4 | PATOU GARY | XENE | Stock Option (Right to Buy) | D | 18,56 | 10 000 | 10 000 | |||||
| 2021-06-04 | 2021-03-17 | 4 | PATOU GARY See Note | XENE | Common Shares | I | 19,4900 | 100 | 2 | 100 | ||||
| 2021-06-03 | 2021-06-03 | 4 | Svoronos Dawn | XENE | Stock Option (Right to Buy) | D | 18,56 | 10 000 | 10 000 | |||||
| 2021-06-03 | 2021-06-03 | 4 | Machado Patrick | XENE | Stock Option (Right to Buy) | D | 18,56 | 10 000 | 10 000 | |||||
| 2021-06-03 | 2021-06-03 | 4 | Hayden Michael R | XENE | Stock Option (Right to Buy) | D | 18,56 | 10 000 | 10 000 | |||||
| 2021-06-03 | 2021-06-03 | 4 | GANNON STEVEN | XENE | Stock Option (Right to Buy) | D | 18,56 | 10 000 | 10 000 | |||||
| 2021-06-03 | 2021-06-03 | 4 | AZAB MOHAMMAD | XENE | Stock Option (Right to Buy) | D | 18,56 | 10 000 | 10 000 | |||||
| 2021-06-03 | 2021-06-03 | 4 | GAROFALO ELIZABETH A. | XENE | Stock Option (Right to Buy) | D | 18,56 | 20 000 | 20 000 | |||||
| 2021-06-03 | 3 | GAROFALO ELIZABETH A. | XENE | No securities are beneficially owned. | D | 0 | ||||||||
| 2021-06-03 | 2021-06-03 | 4 | MORTIMER IAN | XENE | Stock Option (Right to Buy) | D | 18,56 | 125 000 | 125 000 | |||||
| 2021-06-03 | 2021-06-03 | 4 | AULIN SHERRY | XENE | Stock Option (Right to Buy) | D | 18,56 | 100 000 | 100 000 | |||||
| 2021-06-03 | 3 | AULIN SHERRY | XENE | No securities are beneficially owned. | D | 0 | ||||||||
| 2021-06-01 | 2021-05-28 | 4 | ROBIN SHERRINGTON | XENE | Stock Option (Right to Buy) | D | 3,85 | −13 374 | 0 | |||||
| 2021-06-01 | 2021-05-28 | 4 | ROBIN SHERRINGTON | XENE | Stock Option (Right to Buy) | D | 3,76 | −12 345 | 0 | |||||
| 2021-06-01 | 2021-05-28 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 18,8100 | −2 912 | −55 | 32 232 | ||||
| 2021-06-01 | 2021-05-28 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 18,8100 | −3 155 | −59 | 35 144 | ||||
| 2021-06-01 | 2021-05-28 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 18,9100 | −2 192 | −41 | 38 299 | ||||
| 2021-06-01 | 2021-05-28 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 3,8500 | 13 374 | 51 | 40 491 | ||||
| 2021-06-01 | 2021-05-28 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 18,9100 | −2 024 | −38 | 27 117 | ||||
| 2021-06-01 | 2021-05-28 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 3,7600 | 12 345 | 46 | 29 141 | ||||
| 2021-06-01 | 2021-05-27 | 4 | HOLLER FRANK A | XENE | Stock Option (Right to Buy) | D | 3,76 | −36 008 | 0 | |||||
| 2021-06-01 | 2021-05-27 | 4 | HOLLER FRANK A | XENE | Stock Option (Right to Buy) | D | 3,76 | −3 086 | 0 | |||||
| 2021-06-01 | 2021-05-27 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 18,6800 | −8 485 | −158 | 143 653 | ||||
| 2021-06-01 | 2021-05-27 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 18,6900 | −2 579 | −48 | 152 138 | ||||
| 2021-06-01 | 2021-05-27 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 18,8800 | −5 911 | −112 | 154 717 | ||||
| 2021-06-01 | 2021-05-27 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 3,7600 | 36 008 | 135 | 160 628 | ||||
| 2021-06-01 | 2021-05-27 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 18,8800 | −507 | −10 | 124 620 | ||||
| 2021-06-01 | 2021-05-27 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 3,7600 | 3 086 | 12 | 125 127 | ||||
| 2021-05-26 | 2021-05-24 | 4 | PIMSTONE SIMON N. | XENE | Stock Option (Right to Buy) | D | 3,76 | −22 633 | 0 | |||||
| 2021-05-26 | 2021-05-24 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 19,1700 | −5 076 | −97 | 227 743 | ||||
| 2021-05-26 | 2021-05-24 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 3,7600 | 22 633 | 85 | 232 819 | ||||
| 2021-05-20 | 2021-05-18 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 3,67 | −5 144 | 0 | |||||
| 2021-05-20 | 2021-05-18 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 3,67 | −1 028 | 0 | |||||
| 2021-05-20 | 2021-05-18 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 3,87 | −2 057 | 0 | |||||
| 2021-05-20 | 2021-05-18 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | 3,6700 | 5 144 | 19 | 77 942 | ||||
| 2021-05-20 | 2021-05-18 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | 3,6700 | 1 028 | 4 | 72 798 | ||||
| 2021-05-20 | 2021-05-18 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | 3,8700 | 2 057 | 8 | 71 770 | ||||
| 2021-05-20 | 2021-05-18 | 4 | Hayden Michael R | XENE | Stock Option (Right to Buy) | D | 3,85 | −3 500 | 0 | |||||
| 2021-05-20 | 2021-05-18 | 4 | Hayden Michael R | XENE | Common Shares | D | 3,8500 | 3 500 | 13 | 116 206 | ||||
| 2021-03-15 | 2021-03-12 | 4 | EMPFIELD JAMES R. | XENE | Stock Option (Right to Buy) | D | 20,55 | 65 000 | 65 000 | |||||
| 2021-03-15 | 2021-03-12 | 4 | Von Seggern Christopher | XENE | Stock Option (Right to Buy) | D | 20,55 | 60 000 | 60 000 | |||||
| 2021-03-15 | 2021-03-12 | 4 | ROBIN SHERRINGTON | XENE | Stock Option (Right to Buy) | D | 20,55 | 65 000 | 65 000 | |||||
| 2021-03-15 | 2021-03-12 | 4 | MORTIMER IAN | XENE | Stock Option (Right to Buy) | D | 20,55 | 100 000 | 100 000 | |||||
| 2021-03-15 | 2021-03-12 | 4 | PIMSTONE SIMON N. | XENE | Stock Option (Right to Buy) | D | 20,55 | 225 000 | 225 000 | |||||
| 2021-02-18 | 2021-02-18 | 4 | Hayden Michael R By Genworks Inc. | XENE | Stock Option (Right to Buy) | I | 2,68 | −30 864 | 0 | |||||
| 2021-02-18 | 2021-02-18 | 4 | Hayden Michael R By Genworks Inc. | XENE | Stock Option (Right to Buy) | I | 3,67 | −10 288 | 0 | |||||
| 2021-02-18 | 2021-02-18 | 4 | Hayden Michael R By Genworks Inc. | XENE | Common Shares | I | 2,6800 | 30 864 | 83 | 92 076 | ||||
| 2021-02-18 | 2021-02-18 | 4 | Hayden Michael R By Genworks Inc. | XENE | Common Shares | I | 3,6700 | 10 288 | 38 | 61 212 | ||||
| 2021-02-18 | 2021-02-16 | 4 | Hayden Michael R | XENE | Stock Option (Right to Buy) | D | 2,68 | −5 144 | 0 | |||||
| 2021-02-18 | 2021-02-16 | 4 | Hayden Michael R | XENE | Common Shares | D | 2,6800 | 5 144 | 14 | 112 706 | ||||
| 2020-12-15 | 2020-12-15 | 4 | AZAB MOHAMMAD | XENE | Stock Option (Right to Buy) | D | 3,76 | −3 086 | 0 | |||||
| 2020-12-15 | 2020-12-15 | 4 | AZAB MOHAMMAD | XENE | Common Shares | D | 3,7600 | 3 086 | 12 | 63 733 | ||||
| 2020-11-05 | 2020-11-05 | 4 | Machado Patrick | XENE | Stock Option (Right to Buy) | D | 11,85 | 20 000 | 20 000 | |||||
| 2020-11-05 | 3 | Machado Patrick | XENE | No securities are beneficially owned | D | 0 | ||||||||
| 2020-10-29 | 2020-10-28 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 3,76 | −5 144 | 0 | |||||
| 2020-10-29 | 2020-10-28 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 3,76 | −5 144 | 0 | |||||
| 2020-10-29 | 2020-10-28 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | −10 288 | 69 713 | ||||||
| 2020-10-29 | 2020-10-28 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | 3,7600 | 5 144 | 19 | 80 001 | ||||
| 2020-10-29 | 2020-10-28 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | 3,7600 | 5 144 | 19 | 80 001 | ||||
| 2020-10-29 | 2020-10-28 | 4 | PATOU GARY | XENE | Stock Option (Right to Buy) | D | 3,76 | −2 057 | 0 | |||||
| 2020-10-29 | 2020-10-28 | 4 | PATOU GARY | XENE | Common Shares | D | 3,7600 | 2 057 | 8 | 23 573 | ||||
| 2020-08-24 | 2020-08-20 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | −45 000 | 210 186 | ||||||
| 2020-08-17 | 2020-08-17 | 4 | Von Seggern Christopher | XENE | Stock Option (Right to Buy) | D | 11,27 | 100 000 | 100 000 | |||||
| 2020-08-17 | 3 | Von Seggern Christopher | XENE | No securities are beneficially owned. | D | 0 | ||||||||
| 2020-06-10 | 2020-06-09 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 3,52 | −5 144 | 0 | |||||
| 2020-06-10 | 2020-06-09 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | 3,5200 | 5 144 | 18 | 69 713 | ||||
| 2020-06-02 | 2020-06-01 | 4 | PATOU GARY | XENE | Stock Option (Right to Buy) | D | 13,11 | 10 000 | 10 000 | |||||
| 2020-06-02 | 2020-06-01 | 4 | ROBIN SHERRINGTON | XENE | Stock Option (Right to Buy) | D | 3,56 | −8 230 | 0 | |||||
| 2020-06-02 | 2020-06-01 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 13,7000 | −1 630 | −22 | 16 796 | ||||
| 2020-06-02 | 2020-06-01 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 3,5600 | 8 230 | 29 | 18 426 | ||||
| 2020-06-02 | 2020-06-01 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 14,4300 | −3 000 | −43 | 255 186 | ||||
| 2020-06-02 | 2020-05-29 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 13,9900 | −5 000 | −70 | 258 186 | ||||
| 2020-06-02 | 2020-06-01 | 4 | HOLLER FRANK A | XENE | Stock Option (Right to Buy) | D | 13,11 | 10 000 | 10 000 | |||||
| 2020-06-02 | 2020-05-29 | 4 | HOLLER FRANK A | XENE | Stock Option (Right to Buy) | D | 3,56 | −3 086 | 0 | |||||
| 2020-06-02 | 2020-05-29 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 3,5600 | 3 086 | 11 | 122 041 | ||||
| 2020-06-02 | 2020-06-01 | 4 | AZAB MOHAMMAD | XENE | Stock Option (Right to Buy) | D | 13,11 | 10 000 | 10 000 | |||||
| 2020-06-02 | 2020-06-01 | 4 | Desjardins Clarissa | XENE | Stock Option (Right to Buy) | D | 13,11 | 10 000 | 10 000 | |||||
| 2020-06-02 | 2020-06-01 | 4 | GANNON STEVEN | XENE | Stock Option (Right to Buy) | D | 13,11 | 10 000 | 10 000 | |||||
| 2020-06-02 | 2020-06-01 | 4 | Hayden Michael R | XENE | Stock Option (Right to Buy) | D | 13,11 | 10 000 | 10 000 | |||||
| 2020-06-02 | 2020-06-01 | 4 | Svoronos Dawn | XENE | Stock Option (Right to Buy) | D | 13,11 | 10 000 | 10 000 | |||||
| 2020-06-02 | 2020-06-01 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 13,11 | 10 000 | 10 000 | |||||
| 2020-05-28 | 2020-05-26 | 4 | PIMSTONE SIMON N. | XENE | Stock Option (Right to Buy) | D | 3,56 | −6 172 | 0 | |||||
| 2020-05-28 | 2020-05-26 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 14,9000 | −1 108 | −17 | 263 186 | ||||
| 2020-05-28 | 2020-05-26 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 3,5600 | 6 172 | 22 | 264 294 | ||||
| 2020-03-13 | 2020-03-12 | 4 | ROBIN SHERRINGTON | XENE | Stock Option (Right to Buy) | D | 11,58 | 65 000 | 65 000 | |||||
| 2020-03-13 | 2020-03-12 | 4 | EMPFIELD JAMES R. | XENE | Stock Option (Right to Buy) | D | 11,58 | 65 000 | 65 000 | |||||
| 2020-03-13 | 2020-03-12 | 4 | MORTIMER IAN | XENE | Stock Option (Right to Buy) | D | 11,58 | 145 000 | 145 000 | |||||
| 2020-03-13 | 2020-03-12 | 4 | AYCARDI-FONSECA ERNESTO | XENE | Stock Option (Right to Buy) | D | 11,58 | 65 000 | 65 000 | |||||
| 2020-03-13 | 2020-03-12 | 4 | PIMSTONE SIMON N. | XENE | Stock Option (Right to Buy) | D | 11,58 | 280 000 | 280 000 | |||||
| 2020-01-14 | 2020-01-13 | 4 | Desjardins Clarissa | XENE | Stock Option (Right to Buy) | D | 16,42 | 25 000 | 25 000 | |||||
| 2020-01-14 | 3 | Desjardins Clarissa | XENE | No securities are beneficially owned | D | 0 | ||||||||
| 2019-12-17 | 2019-12-16 | 4 | AZAB MOHAMMAD | XENE | Stock Option (Right to Buy) | D | 3,56 | −3 086 | 0 | |||||
| 2019-12-17 | 2019-12-16 | 4 | AZAB MOHAMMAD | XENE | Common Shares | D | 3,5600 | 3 086 | 11 | 60 647 | ||||
| 2019-12-06 | 2019-12-04 | 4 | PATOU GARY | XENE | Stock Option (Right to Buy) | D | 3,56 | −2 057 | 0 | |||||
| 2019-12-06 | 2019-12-04 | 4 | PATOU GARY | XENE | Common Shares | D | 3,5600 | 2 057 | 7 | 21 516 | ||||
| 2019-11-22 | 2019-11-21 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 3,51 | −2 057 | 0 | |||||
| 2019-11-22 | 2019-11-21 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 3,56 | −5 144 | 0 | |||||
| 2019-11-22 | 2019-11-21 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | −2 057 | 64 569 | ||||||
| 2019-11-22 | 2019-11-21 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | 3,5100 | 2 057 | 7 | 66 626 | ||||
| 2019-11-22 | 2019-11-21 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | −5 144 | 64 569 | ||||||
| 2019-11-22 | 2019-11-21 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | 3,5600 | 5 144 | 18 | 69 713 | ||||
| 2019-09-24 | 2019-09-20 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 9,5100 | −10 395 | −99 | 258 122 | ||||
| 2019-09-20 | 2019-09-20 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 9,3900 | −5 206 | −49 | 118 955 | ||||
| 2019-09-20 | 2019-09-19 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 9,2700 | −7 600 | −70 | 124 161 | ||||
| 2019-09-18 | 2019-09-16 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 9,44 | 15 000 | 15 000 | |||||
| 2019-09-18 | 2019-09-16 | 4 | SCHELLER RICHARD H | XENE | Stock Option (Right to Buy) | D | 9,44 | 15 000 | 15 000 | |||||
| 2019-09-18 | 2019-09-16 | 4 | ROBIN SHERRINGTON | XENE | Stock Option (Right to Buy) | D | 9,44 | 45 000 | 45 000 | |||||
| 2019-09-18 | 2019-09-16 | 4 | Svoronos Dawn | XENE | Stock Option (Right to Buy) | D | 9,44 | 15 000 | 15 000 | |||||
| 2019-09-18 | 2019-09-17 | 4 | PIMSTONE SIMON N. | XENE | Stock Option (Right to Buy) | D | 3,38 | −12 345 | 0 | |||||
| 2019-09-18 | 2019-09-17 | 4 | PIMSTONE SIMON N. | XENE | Stock Option (Right to Buy) | D | 3,07 | −9 259 | 0 | |||||
| 2019-09-18 | 2019-09-17 | 4 | PIMSTONE SIMON N. | XENE | Stock Option (Right to Buy) | D | 3,70 | −36 008 | 0 | |||||
| 2019-09-18 | 2019-09-17 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 9,4400 | −3 692 | −35 | 268 517 | ||||
| 2019-09-18 | 2019-09-17 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 3,3800 | 12 345 | 42 | 272 209 | ||||
| 2019-09-18 | 2019-09-17 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 9,4400 | −2 769 | −26 | 259 864 | ||||
| 2019-09-18 | 2019-09-17 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 3,0700 | 9 259 | 28 | 262 633 | ||||
| 2019-09-18 | 2019-09-17 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 9,4400 | −10 769 | −102 | 253 374 | ||||
| 2019-09-18 | 2019-09-17 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 3,7000 | 36 008 | 133 | 264 143 | ||||
| 2019-09-18 | 2019-09-16 | 4 | PIMSTONE SIMON N. | XENE | Stock Option (Right to Buy) | D | 9,44 | 280 000 | 280 000 | |||||
| 2019-09-18 | 2019-09-18 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 9,2800 | −4 368 | −41 | 131 761 | ||||
| 2019-09-18 | 2019-09-17 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 9,3200 | −5 069 | −47 | 136 129 | ||||
| 2019-09-18 | 2019-09-16 | 4 | HOLLER FRANK A | XENE | Stock Option (Right to Buy) | D | 9,44 | 15 000 | 15 000 | |||||
| 2019-09-18 | 2019-09-16 | 4 | MORTIMER IAN | XENE | Stock Option (Right to Buy) | D | 9,44 | 135 000 | 135 000 | |||||
| 2019-09-18 | 2019-09-16 | 4 | PATOU GARY | XENE | Stock Option (Right to Buy) | D | 9,44 | 15 000 | 15 000 | |||||
| 2019-09-18 | 2019-09-16 | 4 | EMPFIELD JAMES R. | XENE | Stock Option (Right to Buy) | D | 9,44 | 40 000 | 40 000 | |||||
| 2019-09-18 | 2019-09-16 | 4 | GANNON STEVEN | XENE | Stock Option (Right to Buy) | D | 9,44 | 15 000 | 15 000 | |||||
| 2019-09-18 | 2019-09-16 | 4 | Hayden Michael R | XENE | Stock Option (Right to Buy) | D | 9,44 | 15 000 | 15 000 | |||||
| 2019-09-18 | 2019-09-16 | 4 | AYCARDI-FONSECA ERNESTO | XENE | Stock Option (Right to Buy) | D | 9,44 | 65 000 | 65 000 | |||||
| 2019-09-17 | 2019-09-16 | 4 | AZAB MOHAMMAD | XENE | Stock Option (Right to Buy) | D | 9,44 | 15 000 | 15 000 | |||||
| 2019-09-17 | 2019-09-13 | 4 | AZAB MOHAMMAD | XENE | Common Shares | D | 9,3122 | −23 | −0 | 57 561 | ||||
| 2019-09-13 | 2019-09-12 | 4 | HOLLER FRANK A | XENE | Stock Option (Right to Buy) | D | 3,00 | −25 720 | 0 | |||||
| 2019-09-13 | 2019-09-12 | 4 | HOLLER FRANK A | XENE | Stock Option (Right to Buy) | D | 3,07 | −3 086 | 0 | |||||
| 2019-09-13 | 2019-09-12 | 4 | HOLLER FRANK A | XENE | Stock Option (Right to Buy) | D | 3,70 | −3 086 | 0 | |||||
| 2019-09-13 | 2019-09-12 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 9,3800 | −7 781 | −73 | 141 198 | ||||
| 2019-09-13 | 2019-09-12 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 3,0000 | 25 720 | 77 | 148 979 | ||||
| 2019-09-13 | 2019-09-12 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 9,3800 | −934 | −9 | 123 259 | ||||
| 2019-09-13 | 2019-09-12 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 9,3800 | −934 | −9 | 123 259 | ||||
| 2019-09-13 | 2019-09-12 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 3,0700 | 3 086 | 9 | 124 193 | ||||
| 2019-09-13 | 2019-09-12 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 3,7000 | 3 086 | 11 | 122 041 | ||||
| 2019-09-13 | 2019-09-12 | 4 | ROBIN SHERRINGTON | XENE | Stock Option (Right to Buy) | D | 3,07 | −6 172 | 0 | |||||
| 2019-09-13 | 2019-09-12 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 9,3800 | −1 868 | −18 | 10 196 | ||||
| 2019-09-13 | 2019-09-12 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 3,0700 | 6 172 | 19 | 12 064 | ||||
| 2019-05-23 | 2019-05-21 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 3,21 | −2 057 | 0 | |||||
| 2019-05-23 | 2019-05-21 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | 3,2100 | 2 057 | 7 | 64 569 | ||||
| 2019-03-20 | 2019-03-19 | 4 | Hayden Michael R By Genworks Inc. | XENE | Stock Option (Right to Buy) | I | 3,38 | −20 576 | 0 | |||||
| 2019-03-20 | 2019-03-19 | 4 | Hayden Michael R By Genworks Inc. | XENE | Common Shares | I | 3,3800 | 20 576 | 70 | 50 924 | ||||
| 2019-03-12 | 2019-03-11 | 4 | Hayden Michael R By Spouse | XENE | Common Shares | I | 17 337 | 114 403 | ||||||
| 2019-03-12 | 2019-03-11 | 4 | Hayden Michael R | XENE | Common Shares | D | −24 045 | 107 562 | ||||||
| 2018-12-26 | 2018-12-21 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | −5 000 | 62 512 | ||||||
| 2018-12-18 | 2018-12-14 | 4 | PATOU GARY | XENE | Stock Option (Right to Buy) | D | 3,07 | −2 057 | 0 | |||||
| 2018-12-18 | 2018-12-14 | 4 | PATOU GARY | XENE | Common Shares | D | 3,0700 | 2 057 | 6 | 19 459 | ||||
| 2018-12-13 | 2018-12-11 | 4 | COHEN CHARLES J. | XENE | Stock Option (Right to Buy) | D | 3,07 | −4 115 | 0 | |||||
| 2018-12-13 | 2018-12-11 | 4 | COHEN CHARLES J. | XENE | Common Shares | D | 7,0000 | −1 644 | −12 | 6 550 | ||||
| 2018-12-13 | 2018-12-11 | 4 | COHEN CHARLES J. | XENE | Common Shares | D | 3,0700 | 4 115 | 13 | 8 194 | ||||
| 2018-12-10 | 2018-12-06 | 4 | AZAB MOHAMMAD | XENE | Stock Option (Right to Buy) | D | 3,07 | −3 086 | 0 | |||||
| 2018-12-10 | 2018-12-06 | 4 | AZAB MOHAMMAD | XENE | Common Shares | D | 3,0700 | 3 086 | 9 | 57 584 | ||||
| 2018-06-22 | 2018-06-21 | 4 | AZAB MOHAMMAD | XENE | Stock Option (Right to Buy) | D | 3,70 | −10 288 | 0 | |||||
| 2018-06-22 | 2018-06-21 | 4 | AZAB MOHAMMAD | XENE | Common Shares | D | 3,7000 | 10 288 | 38 | 54 498 | ||||
| 2018-06-22 | 2018-06-21 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 3,07 | −5 144 | 0 | |||||
| 2018-06-22 | 2018-06-21 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 3,70 | −5 144 | 0 | |||||
| 2018-06-22 | 2018-06-21 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 3,66 | −2 057 | 0 | |||||
| 2018-06-22 | 2018-06-21 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | 3,0700 | 5 144 | 16 | 67 512 | ||||
| 2018-06-22 | 2018-06-21 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | 3,6600 | 2 057 | 8 | 62 368 | ||||
| 2018-06-22 | 2018-06-21 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | 3,7000 | 5 144 | 19 | 60 311 | ||||
| 2018-06-15 | 2018-06-14 | 4 | PATOU GARY | XENE | Stock Option (Right to Buy) | D | 3,70 | −8 230 | 0 | |||||
| 2018-06-15 | 2018-06-14 | 4 | PATOU GARY | XENE | Common Shares | D | 8,3000 | −2 856 | −24 | 17 402 | ||||
| 2018-06-15 | 2018-06-14 | 4 | PATOU GARY | XENE | Common Shares | D | 3,7000 | 8 230 | 30 | 20 258 | ||||
| 2018-06-05 | 2018-06-04 | 4 | AZAB MOHAMMAD | XENE | Stock Option (Right to Buy) | D | 6,20 | 15 000 | 15 000 | |||||
| 2018-06-05 | 2018-06-04 | 4 | GANNON STEVEN | XENE | Stock Option (Right to Buy) | D | 6,20 | 15 000 | 15 000 | |||||
| 2018-06-05 | 2018-06-04 | 4 | Hayden Michael R | XENE | Stock Option (Right to Buy) | D | 6,20 | 15 000 | 15 000 | |||||
| 2018-06-05 | 2018-06-04 | 4 | HOLLER FRANK A | XENE | Stock Option (Right to Buy) | D | 6,20 | 15 000 | 15 000 | |||||
| 2018-06-05 | 2018-06-04 | 4 | PATOU GARY | XENE | Stock Option (Right to Buy) | D | 6,20 | 15 000 | 15 000 | |||||
| 2018-06-05 | 2018-06-04 | 4 | SCHELLER RICHARD H | XENE | Stock Option (Right to Buy) | D | 6,20 | 15 000 | 15 000 | |||||
| 2018-06-05 | 2018-06-04 | 4 | Svoronos Dawn | XENE | Stock Option (Right to Buy) | D | 6,20 | 15 000 | 15 000 | |||||
| 2018-06-05 | 2018-06-04 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 6,20 | 15 000 | 15 000 | |||||
| 2018-03-29 | 2018-03-27 | 4 | BVF PARTNERS L P/IL | XENE | Series 1 Preferred Shares | D | 238 000 | 238 000 | ||||||
| 2018-03-29 | 2018-03-27 | 4 | BVF PARTNERS L P/IL | XENE | Series 1 Preferred Shares | D | 861 000 | 861 000 | ||||||
| 2018-03-29 | 2018-03-27 | 4 | BVF PARTNERS L P/IL | XENE | Series 1 Preferred Shares | D | 1 338 000 | 1 338 000 | ||||||
| 2018-03-29 | 2018-03-27 | 4 | BVF PARTNERS L P/IL | XENE | Common Shares, no par value per share | D | −238 000 | 59 464 | ||||||
| 2018-03-29 | 2018-03-27 | 4 | BVF PARTNERS L P/IL | XENE | Common Shares, no par value per share | D | −861 000 | 216 694 | ||||||
| 2018-03-29 | 2018-03-27 | 4 | BVF PARTNERS L P/IL | XENE | Common Shares, no par value per share | D | −1 338 000 | 336 468 | ||||||
| 2018-03-20 | 3 | AYCARDI-FONSECA ERNESTO | XENE | No securities are beneficially owned | D | 0 | ||||||||
| 2018-03-20 | 2018-03-19 | 4 | AYCARDI-FONSECA ERNESTO | XENE | Stock Option (Right to Buy) | D | 4,65 | 50 000 | 50 000 | |||||
| 2018-03-16 | 2018-03-14 | 4 | HOLLER FRANK A | XENE | Stock Option (Right to Buy) | D | 3,77 | −3 086 | 0 | |||||
| 2018-03-16 | 2018-03-14 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 3,7700 | 3 086 | 12 | 118 955 | ||||
| 2018-03-16 | 2018-03-15 | 4 | ROBIN SHERRINGTON | XENE | Stock Option (Right to Buy) | D | 3,77 | −3 086 | 0 | |||||
| 2018-03-16 | 2018-03-15 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 4,6250 | −1 928 | −9 | 5 892 | ||||
| 2018-03-16 | 2018-03-15 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 3,7700 | 3 086 | 12 | 7 820 | ||||
| 2018-03-14 | 2018-03-12 | 4 | PIMSTONE SIMON N. | XENE | Stock Option (Right to Buy) | D | 3,77 | −10 288 | 0 | |||||
| 2018-03-14 | 2018-03-12 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 3,7700 | 10 288 | 39 | 228 135 | ||||
| 2018-03-13 | 2018-03-12 | 4 | PIMSTONE SIMON N. | XENE | Stock Option (Right to Buy) | D | 4,75 | 140 000 | 140 000 | |||||
| 2018-03-13 | 2018-03-12 | 4 | MORTIMER IAN | XENE | Stock Option (Right to Buy) | D | 4,75 | 105 000 | 105 000 | |||||
| 2018-03-13 | 2018-03-12 | 4 | ROBIN SHERRINGTON | XENE | Stock Option (Right to Buy) | D | 4,75 | 55 000 | 55 000 | |||||
| 2018-03-13 | 2018-03-12 | 4 | EMPFIELD JAMES R. | XENE | Stock Option (Right to Buy) | D | 4,75 | 45 000 | 45 000 | |||||
| 2018-03-13 | 2018-03-12 | 4 | COHEN CHARLES J. | XENE | Stock Option (Right to Buy) | D | 4,75 | 40 000 | 40 000 | |||||
| 2018-03-01 | 2018-02-22 | 4 | Hayden Michael R By Spouse | XENE | Common Shares | I | 21 180 | 97 066 | ||||||
| 2018-03-01 | 2018-02-22 | 4 | Hayden Michael R | XENE | Common Shares | D | −29 580 | 131 607 | ||||||
| 2018-02-14 | 2018-02-12 | 4 | COHEN CHARLES J. | XENE | Stock Option (Right to Buy) | D | 3,71 | −26 748 | 0 | |||||
| 2018-02-14 | 2018-02-12 | 4 | COHEN CHARLES J. | XENE | Common Shares | D | 3,5000 | −22 669 | −79 | 4 079 | ||||
| 2018-02-14 | 2018-02-12 | 4 | COHEN CHARLES J. | XENE | Common Shares | D | 3,7100 | 26 748 | 99 | 26 748 | ||||
| 2017-11-16 | 2017-11-15 | 4 | AZAB MOHAMMAD | XENE | Common Shares | D | 2,2187 | 15 000 | 33 | 44 210 | ||||
| 2017-10-24 | 2017-10-23 | 4 | COHEN CHARLES J. | XENE | Stock Option (Right to Buy) | D | 3,10 | 11 000 | 11 000 | |||||
| 2017-10-24 | 2017-10-23 | 4 | EMPFIELD JAMES R. | XENE | Stock Option (Right to Buy) | D | 3,10 | 20 000 | 20 000 | |||||
| 2017-10-24 | 2017-10-23 | 4 | GOLDBERG Y. PAUL | XENE | Stock Option (Right to Buy) | D | 3,10 | 11 000 | 11 000 | |||||
| 2017-10-24 | 2017-10-23 | 4 | PIMSTONE SIMON N. | XENE | Stock Option (Right to Buy) | D | 3,10 | 11 000 | 11 000 | |||||
| 2017-10-24 | 2017-10-23 | 4 | ROBIN SHERRINGTON | XENE | Stock Option (Right to Buy) | D | 3,10 | 11 000 | 11 000 | |||||
| 2017-10-24 | 2017-10-23 | 4 | MORTIMER IAN | XENE | Stock Option (Right to Buy) | D | 3,10 | 25 000 | 25 000 | |||||
| 2017-09-25 | 2017-09-22 | 4 | AZAB MOHAMMAD | XENE | Common Shares | D | 2,9500 | 8 000 | 24 | 29 210 | ||||
| 2017-09-25 | 2017-09-21 | 4 | AZAB MOHAMMAD | XENE | Common Shares | D | 2,9500 | 2 000 | 6 | 21 210 | ||||
| 2017-08-21 | 2017-08-18 | 4 | WINQUIST RAYMOND | XENE | Common Shares | D | 2,9950 | 1 000 | 3 | 1 000 | ||||
| 2017-08-21 | 2017-08-18 | 4 | AZAB MOHAMMAD | XENE | Common Shares | D | 2,8995 | 6 312 | 18 | 19 210 | ||||
| 2017-08-21 | 2017-08-17 | 4 | AZAB MOHAMMAD | XENE | Common Shares | D | 2,6500 | 23 | 0 | 12 898 | ||||
| 2017-08-17 | 2017-08-15 | 4 | EMPFIELD JAMES R. | XENE | Common Shares | D | 2,4824 | 10 000 | 25 | 10 000 | ||||
| 2017-08-16 | 2017-08-15 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 2,4122 | 7 429 | 18 | 1 077 694 | ||||
| 2017-08-16 | 2017-08-15 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 2,4122 | 11 429 | 28 | 1 674 468 | ||||
| 2017-08-16 | 2017-08-14 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 2,7036 | 13 337 | 36 | 1 070 265 | ||||
| 2017-08-16 | 2017-08-14 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 2,7036 | 28 007 | 76 | 1 663 039 | ||||
| 2017-08-15 | 2017-08-14 | 4 | Svoronos Dawn | XENE | Common Shares | D | 2,8154 | 50 000 | 141 | 50 000 | ||||
| 2017-08-14 | 2017-08-11 | 4 | GANNON STEVEN | XENE | Common Shares | D | 2,8178 | 15 000 | 42 | 15 000 | ||||
| 2017-08-14 | 2017-08-14 | 4 | Hayden Michael R | XENE | Common Shares | D | 2,7498 | 15 000 | 41 | 161 187 | ||||
| 2017-08-14 | 2017-08-10 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 2,9000 | 6 000 | 17 | 217 847 | ||||
| 2017-08-14 | 2017-08-10 | 4 | SCHELLER RICHARD H | XENE | Common Shares | D | 2,8500 | 7 000 | 20 | 7 000 | ||||
| 2017-08-14 | 2017-08-10 | 4 | MORTIMER IAN By Spouse | XENE | Common Stock | I | 2,9000 | 10 000 | 29 | 14 300 | ||||
| 2017-08-14 | 2017-08-10 | 4 | MORTIMER IAN | XENE | Common Stock | D | 2,8450 | 5 000 | 14 | 6 000 | ||||
| 2017-08-14 | 2017-08-10 | 4 | PATOU GARY See Note | XENE | Common Stock | I | 2,7781 | 7 500 | 21 | 12 500 | ||||
| 2017-08-10 | 2017-08-08 | 4 | PATOU GARY See note | XENE | Common Stock | I | 3,0005 | 5 000 | 15 | 5 000 | ||||
| 2017-06-30 | 2017-06-27 | 4/A | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 3,0361 | 8 496 | 26 | 297 464 | ||||
| 2017-06-30 | 2017-06-27 | 4/A | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 3,0361 | 30 170 | 92 | 1 056 928 | ||||
| 2017-06-30 | 2017-06-27 | 4/A | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 3,0361 | 46 795 | 142 | 1 635 032 | ||||
| 2017-06-29 | 2017-06-27 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 4,0000 | 8 496 | 34 | 297 464 | ||||
| 2017-06-29 | 2017-06-27 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 4,0000 | 30 170 | 121 | 1 056 928 | ||||
| 2017-06-29 | 2017-06-27 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 4,0000 | 46 795 | 187 | 1 635 032 | ||||
| 2017-06-23 | 2017-06-22 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 4,0000 | 854 | 3 | 288 968 | ||||
| 2017-06-23 | 2017-06-22 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 4,0000 | 2 884 | 12 | 1 026 758 | ||||
| 2017-06-23 | 2017-06-22 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 4,0000 | 4 525 | 18 | 1 588 237 | ||||
| 2017-06-23 | 2017-06-21 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 4,0000 | 1 362 | 5 | 288 114 | ||||
| 2017-06-23 | 2017-06-21 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 4,0000 | 4 406 | 18 | 1 023 874 | ||||
| 2017-06-23 | 2017-06-21 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 4,0000 | 6 380 | 26 | 1 583 712 | ||||
| 2017-06-20 | 2017-06-19 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 3,51 | −1 028 | 0 | |||||
| 2017-06-20 | 2017-06-19 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | −1 028 | 55 167 | ||||||
| 2017-06-20 | 2017-06-19 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | 3,5100 | 1 028 | 4 | 56 195 | ||||
| 2017-06-19 | 2017-06-19 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 3,8500 | 357 | 1 | 286 752 | ||||
| 2017-06-19 | 2017-06-19 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 3,8500 | 1 271 | 5 | 1 019 468 | ||||
| 2017-06-19 | 2017-06-19 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 3,8500 | 1 967 | 8 | 1 577 332 | ||||
| 2017-06-19 | 2017-06-16 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 3,8500 | 1 064 | 4 | 286 395 | ||||
| 2017-06-19 | 2017-06-16 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 3,8500 | 3 873 | 15 | 1 018 197 | ||||
| 2017-06-19 | 2017-06-16 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 3,8500 | 6 097 | 23 | 1 575 365 | ||||
| 2017-06-19 | 2017-06-15 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 3,8370 | 1 160 | 4 | 285 331 | ||||
| 2017-06-19 | 2017-06-15 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 3,8370 | 3 845 | 15 | 1 014 324 | ||||
| 2017-06-19 | 2017-06-15 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 3,8370 | 6 774 | 26 | 1 569 268 | ||||
| 2017-06-08 | 2017-06-07 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 3,8512 | 20 594 | 79 | 284 171 | ||||
| 2017-06-08 | 2017-06-07 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 3,8512 | 73 749 | 284 | 1 010 479 | ||||
| 2017-06-08 | 2017-06-07 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 3,8512 | 113 446 | 437 | 1 562 494 | ||||
| 2017-06-08 | 2017-06-06 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 3,7500 | 913 | 3 | 263 577 | ||||
| 2017-06-08 | 2017-06-06 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 3,7500 | 53 260 | 200 | 936 730 | ||||
| 2017-06-08 | 2017-06-06 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 3,7500 | 96 736 | 363 | 1 449 048 | ||||
| 2017-06-02 | 2017-06-01 | 4 | SCHELLER RICHARD H | XENE | Stock Option (Right to Buy) | D | 3,85 | 3 500 | 3 500 | |||||
| 2017-06-02 | 2017-06-01 | 4 | PATOU GARY | XENE | Stock Option (Right to Buy) | D | 3,85 | 3 500 | 3 500 | |||||
| 2017-06-02 | 2017-06-01 | 4 | GANNON STEVEN | XENE | Stock Option (Right to Buy) | D | 3,85 | 3 500 | 3 500 | |||||
| 2017-06-02 | 2017-06-01 | 4 | AZAB MOHAMMAD | XENE | Stock Option (Right to Buy) | D | 3,85 | 3 500 | 3 500 | |||||
| 2017-06-02 | 2017-06-01 | 4 | Hayden Michael R | XENE | Stock Option (Right to Buy) | D | 3,85 | 3 500 | 3 500 | |||||
| 2017-06-02 | 2017-06-01 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 3,85 | 1 250 | 1 250 | |||||
| 2017-06-02 | 2017-06-01 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 3,85 | 3 500 | 3 500 | |||||
| 2017-06-02 | 2017-06-01 | 4 | Svoronos Dawn | XENE | Stock Option (Right to Buy) | D | 3,85 | 3 500 | 3 500 | |||||
| 2017-06-02 | 2017-06-01 | 4 | HOLLER FRANK A | XENE | Stock Option (Right to Buy) | D | 3,85 | 3 500 | 3 500 | |||||
| 2017-05-16 | 2017-05-12 | 4 | ROBIN SHERRINGTON | XENE | Stock Option (Right to Buy) | D | 3,21 | −2 057 | 0 | |||||
| 2017-05-16 | 2017-05-12 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 4,1800 | −1 345 | −6 | 4 734 | ||||
| 2017-05-16 | 2017-05-12 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 3,2100 | 2 057 | 7 | 6 079 | ||||
| 2017-03-15 | 2017-03-14 | 4 | Hayden Michael R By Genworks Inc. | XENE | Stock Option (Right to Buy) | I | 3,56 | −3 086 | 0 | |||||
| 2017-03-15 | 2017-03-14 | 4 | Hayden Michael R By Genworks Inc. | XENE | Stock Option (Right to Buy) | I | 3,07 | −4 629 | 0 | |||||
| 2017-03-15 | 2017-03-14 | 4 | Hayden Michael R By Genworks Inc. | XENE | Stock Option (Right to Buy) | I | 3,77 | −4 115 | 0 | |||||
| 2017-03-15 | 2017-03-14 | 4 | Hayden Michael R | XENE | Stock Option (Right to Buy) | D | 3,67 | −5 144 | 0 | |||||
| 2017-03-15 | 2017-03-14 | 4 | Hayden Michael R | XENE | Stock Option (Right to Buy) | D | 3,76 | −25 720 | 0 | |||||
| 2017-03-15 | 2017-03-14 | 4 | Hayden Michael R | XENE | Stock Option (Right to Buy) | D | 3,70 | −18 004 | 0 | |||||
| 2017-03-15 | 2017-03-14 | 4 | Hayden Michael R By Genworks Inc. | XENE | Common Shares | I | 3,5600 | 3 086 | 11 | 30 348 | ||||
| 2017-03-15 | 2017-03-14 | 4 | Hayden Michael R By Genworks Inc. | XENE | Common Shares | I | 3,0700 | 4 629 | 14 | 27 262 | ||||
| 2017-03-15 | 2017-03-14 | 4 | Hayden Michael R By Genworks Inc. | XENE | Common Shares | I | 3,7700 | 4 115 | 16 | 22 633 | ||||
| 2017-03-15 | 2017-03-14 | 4 | Hayden Michael R | XENE | Common Shares | D | 3,6700 | 5 144 | 19 | 146 187 | ||||
| 2017-03-15 | 2017-03-14 | 4 | Hayden Michael R | XENE | Common Shares | D | 3,7600 | 25 720 | 97 | 141 043 | ||||
| 2017-03-15 | 2017-03-14 | 4 | Hayden Michael R | XENE | Common Shares | D | 3,7000 | 18 004 | 67 | 115 323 | ||||
| 2017-03-14 | 2017-03-13 | 4 | MORTIMER IAN | XENE | Stock Option (Right to Buy) | D | 8,40 | 75 000 | 75 000 | |||||
| 2017-03-14 | 2017-03-13 | 4 | PIMSTONE SIMON N. | XENE | Stock Option (Right to Buy) | D | 8,40 | 140 000 | 140 000 | |||||
| 2017-03-14 | 2017-03-13 | 4 | ROBIN SHERRINGTON | XENE | Stock Option (Right to Buy) | D | 8,40 | 27 500 | 27 500 | |||||
| 2017-03-14 | 2017-03-13 | 4 | WINQUIST RAYMOND | XENE | Stock Option (Right to Buy) | D | 8,40 | 20 000 | 20 000 | |||||
| 2017-03-14 | 2017-03-13 | 4 | COHEN CHARLES J. | XENE | Stock Option (Right to Buy) | D | 8,40 | 20 000 | 20 000 | |||||
| 2017-03-14 | 2017-03-13 | 4 | EMPFIELD JAMES R. | XENE | Stock Option (Right to Buy) | D | 8,40 | 27 500 | 27 500 | |||||
| 2017-03-14 | 2017-03-13 | 4 | GOLDBERG Y. PAUL | XENE | Stock Option (Right to Buy) | D | 8,40 | 27 500 | 27 500 | |||||
| 2017-01-27 | 2017-01-26 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | −7 201 | 55 167 | ||||||
| 2016-12-19 | 2016-12-15 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 7,8500 | −30 000 | −236 | 115 869 | ||||
| 2016-12-13 | 2016-12-12 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 3,21 | −14 403 | 0 | |||||
| 2016-12-13 | 2016-12-12 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | −7 202 | 62 368 | ||||||
| 2016-12-13 | 2016-12-12 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | 3,2100 | 14 403 | 46 | 69 570 | ||||
| 2016-12-08 | 2016-12-06 | 4 | PATOU GARY | XENE | Stock Option (Right to Buy) | D | 3,21 | −12 345 | 0 | |||||
| 2016-12-08 | 2016-12-06 | 4 | PATOU GARY | XENE | Common Shares | D | 7,9000 | −4 403 | −35 | 12 028 | ||||
| 2016-12-08 | 2016-12-06 | 4 | PATOU GARY | XENE | Common Shares | D | 3,2100 | 12 345 | 40 | 16 431 | ||||
| 2016-12-02 | 2016-12-01 | 4 | AZAB MOHAMMAD | XENE | Stock Option (Right to Buy) | D | 3,21 | −12 345 | 0 | |||||
| 2016-12-02 | 2016-12-01 | 4 | AZAB MOHAMMAD | XENE | Common Shares | D | 7,8000 | −4 408 | −34 | 12 875 | ||||
| 2016-12-02 | 2016-12-01 | 4 | AZAB MOHAMMAD | XENE | Common Shares | D | 3,2100 | 12 345 | 40 | 17 283 | ||||
| 2016-09-27 | 3 | Svoronos Dawn | XENE | No securities are beneficially owned | D | 0 | ||||||||
| 2016-09-27 | 2016-09-27 | 4 | Svoronos Dawn | XENE | Stock Option (Right to Buy) | D | 8,15 | 5 144 | 5 144 | |||||
| 2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 3 381 916 | ||||||||
| 2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 2 761 110 | ||||||||
| 2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 2 761 110 | ||||||||
| 2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 3 381 916 | ||||||||
| 2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 3 850 758 | ||||||||
| 2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 2 761 110 | ||||||||
| 2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 3 381 916 | ||||||||
| 2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 3 850 758 | ||||||||
| 2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 2 761 110 | ||||||||
| 2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 3 381 916 | ||||||||
| 2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 3 850 758 | ||||||||
| 2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 2 761 110 | ||||||||
| 2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 3 381 916 | ||||||||
| 2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 3 850 758 | ||||||||
| 2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 2 761 110 | ||||||||
| 2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 3 381 916 | ||||||||
| 2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 3 850 758 | ||||||||
| 2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 2 761 110 | ||||||||
| 2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 3 381 916 | ||||||||
| 2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 3 850 758 | ||||||||
| 2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 3 850 758 | ||||||||
| 2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 3 381 916 | ||||||||
| 2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 3 850 758 | ||||||||
| 2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 2 761 110 | ||||||||
| 2016-08-23 | 2016-08-19 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 7,6510 | −11 938 | −91 | 145 869 | ||||
| 2016-08-18 | 2016-08-18 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 7,7000 | −9 599 | −74 | 157 807 | ||||
| 2016-08-18 | 2016-08-17 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 7,8900 | −1 600 | −13 | 167 406 | ||||
| 2016-08-18 | 2016-08-16 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 8,2500 | −6 863 | −57 | 169 006 | ||||
| 2016-08-02 | 2016-07-29 | 4 | PIMSTONE SIMON N. | XENE | Stock Option (Right to Buy) | D | 3,30 | −12 345 | 0 | |||||
| 2016-08-02 | 2016-07-29 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 7,4600 | −4 703 | −35 | 211 847 | ||||
| 2016-08-02 | 2016-07-29 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 3,3000 | 12 345 | 41 | 216 550 | ||||
| 2016-06-28 | 2016-06-24 | 4 | MORTIMER IAN By spouse | XENE | Common Stock | I | 6,3000 | 1 300 | 8 | 4 300 | ||||
| 2016-06-28 | 2016-06-24 | 4 | MORTIMER IAN By spouse | XENE | Common Stock | I | 6,2500 | 2 000 | 12 | 3 000 | ||||
| 2016-06-28 | 2016-06-24 | 4 | MORTIMER IAN By spouse | XENE | Common Stock | I | 6,1000 | 1 000 | 6 | 1 000 | ||||
| 2016-06-28 | 2016-06-24 | 4 | MORTIMER IAN | XENE | Common Stock | D | 6,1500 | 1 000 | 6 | 1 000 | ||||
| 2016-06-03 | 2016-06-02 | 4 | AZAB MOHAMMAD | XENE | Stock Option (Right to Buy) | D | 7,38 | 3 500 | 3 500 | |||||
| 2016-06-03 | 2016-06-02 | 4 | Hayden Michael R | XENE | Stock Option (Right to Buy) | D | 7,38 | 3 500 | 3 500 | |||||
| 2016-06-03 | 2016-06-02 | 4 | PATOU GARY | XENE | Stock Option (Right to Buy) | D | 7,38 | 3 500 | 3 500 | |||||
| 2016-06-03 | 2016-06-02 | 4 | SCHELLER RICHARD H | XENE | Stock Option (Right to Buy) | D | 7,38 | 3 500 | 3 500 | |||||
| 2016-06-03 | 2016-06-02 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 7,38 | 1 250 | 1 250 | |||||
| 2016-06-03 | 2016-06-02 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 7,38 | 3 500 | 3 500 | |||||
| 2016-06-03 | 2016-06-02 | 4 | GANNON STEVEN | XENE | Stock Option (Right to Buy) | D | 7,38 | 3 500 | 3 500 | |||||
| 2016-06-03 | 2016-06-02 | 4 | HOLLER FRANK A | XENE | Stock Option (Right to Buy) | D | 7,38 | 3 500 | 3 500 | |||||
| 2016-05-27 | 2016-05-25 | 4 | Hayden Michael R By Genworks Inc. | XENE | Stock Option (Right to Buy) | I | 3,30 | −8 230 | 0 | |||||
| 2016-05-27 | 2016-05-25 | 4 | Hayden Michael R By Genworks Inc. | XENE | Common Shares | I | 3,3000 | 8 230 | 27 | 18 518 | ||||
| 2016-04-29 | 2016-04-28 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 3,35 | −1 543 | 0 | |||||
| 2016-04-29 | 2016-04-28 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | −1 543 | 55 167 | ||||||
| 2016-04-29 | 2016-04-28 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | 3,3500 | 1 543 | 5 | 56 710 | ||||
| 2016-04-04 | 3 | WINQUIST RAYMOND | XENE | No securities are beneficially owned | D | 0 | ||||||||
| 2016-04-04 | 2016-04-04 | 4 | WINQUIST RAYMOND | XENE | Stock Option (Right to Buy) | D | 7,10 | 35 000 | 35 000 | |||||
| 2016-03-11 | 2016-03-11 | 4 | GOLDBERG Y. PAUL | XENE | Stock Option (Right to Buy) | D | 7,49 | 20 000 | 20 000 | |||||
| 2016-03-11 | 2016-03-11 | 4 | MORTIMER IAN | XENE | Stock Option (Right to Buy) | D | 7,49 | 40 000 | 40 000 | |||||
| 2016-03-11 | 2016-03-11 | 4 | ROBIN SHERRINGTON | XENE | Stock Option (Right to Buy) | D | 7,49 | 20 000 | 20 000 | |||||
| 2016-03-11 | 2016-03-11 | 4 | COHEN CHARLES J. | XENE | Stock Option (Right to Buy) | D | 7,49 | 25 000 | 25 000 | |||||
| 2016-03-11 | 2016-03-11 | 4 | PIMSTONE SIMON N. | XENE | Stock Option (Right to Buy) | D | 7,49 | 50 000 | 50 000 | |||||
| 2016-02-09 | 3 | EMPFIELD JAMES R. | XENE | No securities are beneficially owned | D | 0 | ||||||||
| 2016-02-09 | 2016-02-08 | 4 | EMPFIELD JAMES R. | XENE | Stock Option (Right to Buy) | D | 6,76 | 40 000 | 40 000 | |||||
| 2015-12-21 | 2015-12-18 | 4 | ROBIN SHERRINGTON | XENE | Stock Option (Right to Buy) | D | 7,69 | 15 000 | 15 000 | |||||
| 2015-12-21 | 2015-12-16 | 4 | ROBIN SHERRINGTON | XENE | Stock Option (Right to Buy) | D | 5,22 | −411 | 0 | |||||
| 2015-12-21 | 2015-12-16 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 7,9400 | −229 | −2 | 4 022 | ||||
| 2015-12-21 | 2015-12-16 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 5,2200 | 411 | 2 | 4 251 | ||||
| 2015-12-21 | 2015-12-18 | 4 | PIMSTONE SIMON N. | XENE | Stock Option (Right to Buy) | D | 7,69 | 40 000 | 40 000 | |||||
| 2015-12-21 | 2015-12-18 | 4 | MORTIMER IAN | XENE | Stock Option (Right to Buy) | D | 7,69 | 25 000 | 25 000 | |||||
| 2015-12-21 | 2015-12-18 | 4 | GOLDBERG Y. PAUL | XENE | Stock Option (Right to Buy) | D | 7,69 | 15 000 | 15 000 | |||||
| 2015-12-21 | 2015-12-18 | 4 | COHEN CHARLES J. | XENE | Stock Option (Right to Buy) | D | 7,69 | 15 000 | 15 000 | |||||
| 2015-12-14 | 2015-12-11 | 4 | AZAB MOHAMMAD | XENE | Stock Option (Right to Buy) | D | 5,22 | 2 469 | 0 | |||||
| 2015-12-14 | 2015-12-11 | 4 | AZAB MOHAMMAD | XENE | Common Shares | D | 5,2200 | 2 469 | 13 | 4 938 | ||||
| 2015-11-25 | 2015-11-24 | 4 | HOLLER FRANK A | XENE | Stock Option (Right to Buy) | D | 5,22 | −2 057 | 0 | |||||
| 2015-11-25 | 2015-11-24 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 9,3900 | −995 | −9 | 175 869 | ||||
| 2015-11-25 | 2015-11-24 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 5,2200 | 2 057 | 11 | 176 864 | ||||
| 2015-11-06 | 2015-11-04 | 4 | PATOU GARY | XENE | Stock Option (Right to Buy) | D | 5,22 | −3 497 | 0 | |||||
| 2015-11-06 | 2015-11-04 | 4 | PATOU GARY | XENE | Common Shares | D | 8,3200 | −1 955 | −16 | 4 086 | ||||
| 2015-11-06 | 2015-11-04 | 4 | PATOU GARY | XENE | Common Shares | D | 5,2200 | 3 497 | 18 | 6 041 | ||||
| 2015-11-04 | 2015-11-02 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 5,22 | −5 041 | 0 | |||||
| 2015-11-04 | 2015-11-02 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | −5 041 | 55 167 | ||||||
| 2015-11-04 | 2015-11-02 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | 5,2200 | 5 041 | 26 | 60 208 | ||||
| 2015-09-24 | 2015-09-24 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 8,6000 | −12 000 | −103 | 6 000 | ||||
| 2015-09-24 | 2015-09-23 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 9,0200 | −4 000 | −36 | 18 000 | ||||
| 2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Stock Option (Right to Buy) | D | 2,68 | −785 | 243 | |||||
| 2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Stock Option (Right to Buy) | D | 2,68 | −7 973 | 4 372 | |||||
| 2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Stock Option (Right to Buy) | D | 3,73 | −3 115 | 1 000 | |||||
| 2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Stock Option (Right to Buy) | D | 3,52 | −3 703 | 0 | |||||
| 2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Stock Option (Right to Buy) | D | 3,56 | −6 172 | 0 | |||||
| 2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Stock Option (Right to Buy) | D | 3,07 | −5 144 | 0 | |||||
| 2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Stock Option (Right to Buy) | D | 3,77 | −1 028 | 0 | |||||
| 2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Stock Option (Right to Buy) | D | 3,21 | −2 057 | 0 | |||||
| 2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Stock Option (Right to Buy) | D | 5,22 | −411 | 0 | |||||
| 2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 9,3323 | −6 149 | −57 | 22 000 | ||||
| 2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 9,5300 | −167 | −2 | 28 149 | ||||
| 2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 2,6800 | 785 | 2 | 28 316 | ||||
| 2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 9,5300 | −1 687 | −16 | 27 531 | ||||
| 2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 2,6800 | 7 973 | 21 | 29 218 | ||||
| 2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 9,5300 | −923 | −9 | 21 245 | ||||
| 2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 3,7300 | 3 115 | 12 | 22 168 | ||||
| 2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 9,5300 | −1 098 | −10 | 19 053 | ||||
| 2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 3,5200 | 3 703 | 13 | 20 151 | ||||
| 2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 9,5300 | −1 829 | −17 | 16 448 | ||||
| 2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 3,5600 | 6 172 | 22 | 18 277 | ||||
| 2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 9,5300 | −1 525 | −15 | 12 105 | ||||
| 2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 3,0700 | 5 144 | 16 | 13 630 | ||||
| 2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 9,5300 | −305 | −3 | 8 486 | ||||
| 2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 3,7700 | 1 028 | 4 | 8 791 | ||||
| 2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 9,5300 | −610 | −6 | 7 763 | ||||
| 2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 3,2100 | 2 057 | 7 | 8 373 | ||||
| 2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 9,5300 | −198 | −2 | 6 316 | ||||
| 2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 5,2200 | 411 | 2 | 6 514 | ||||
| 2015-08-20 | 2015-08-18 | 4 | ROBIN SHERRINGTON | XENE | Stock Option (Right to Buy) | D | 4,98 | −2 057 | ||||||
| 2015-08-20 | 2015-08-18 | 4 | ROBIN SHERRINGTON | XENE | Stock Option (Right to Buy) | D | 4,81 | −1 028 | ||||||
| 2015-08-20 | 2015-08-18 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 11,0000 | −868 | −10 | 3 840 | ||||
| 2015-08-20 | 2015-08-18 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 4,9800 | 2 057 | 10 | 4 708 | ||||
| 2015-08-20 | 2015-08-18 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 11,0000 | −434 | −5 | 2 651 | ||||
| 2015-08-20 | 2015-08-18 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 4,8100 | 1 028 | 5 | 3 085 | ||||
| 2015-08-20 | 2015-08-18 | 4 | PIMSTONE SIMON N. | XENE | Stock Option (Right to Buy) | D | 4,98 | −15 432 | 0 | |||||
| 2015-08-20 | 2015-08-18 | 4 | PIMSTONE SIMON N. | XENE | Stock Option (Right to Buy) | D | 4,81 | −5 144 | 0 | |||||
| 2015-08-20 | 2015-08-18 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 11,0000 | −6 508 | −72 | 204 205 | ||||
| 2015-08-20 | 2015-08-18 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 4,9800 | 15 432 | 77 | 210 713 | ||||
| 2015-08-20 | 2015-08-18 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 11,0000 | −2 170 | −24 | 195 281 | ||||
| 2015-08-20 | 2015-08-18 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 4,8100 | 5 144 | 25 | 197 451 | ||||
| 2015-08-20 | 2015-08-18 | 4 | HOLLER FRANK A | XENE | Stock Option (Right to Buy) | D | 4,98 | −2 057 | 0 | |||||
| 2015-08-20 | 2015-08-18 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 11,0000 | −868 | −10 | 174 807 | ||||
| 2015-08-20 | 2015-08-18 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 4,9800 | 2 057 | 10 | 175 675 | ||||
| 2015-08-20 | 2015-08-18 | 4 | GOLDBERG Y. PAUL | XENE | Stock Option (Right to Buy) | D | 4,98 | −2 057 | 0 | |||||
| 2015-08-20 | 2015-08-18 | 4 | GOLDBERG Y. PAUL | XENE | Stock Option (Right to Buy) | D | 4,81 | −1 028 | 0 | |||||
| 2015-08-20 | 2015-08-18 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 11,0000 | −868 | −10 | 6 103 | ||||
| 2015-08-20 | 2015-08-18 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 4,9800 | 2 057 | 10 | 6 971 | ||||
| 2015-08-20 | 2015-08-18 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 11,0000 | −434 | −5 | 4 914 | ||||
| 2015-08-20 | 2015-08-18 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 4,8100 | 1 028 | 5 | 5 348 | ||||
| 2015-06-19 | 2015-06-17 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 4,95 | −1 543 | 0 | |||||
| 2015-06-19 | 2015-06-17 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | 4,9500 | 1 543 | 8 | 55 167 | ||||
| 2015-05-22 | 3 | GANNON STEVEN | XENE | No securities are beneficially owned | D | 0 | ||||||||
| 2015-05-22 | 2015-05-21 | 4 | GANNON STEVEN | XENE | Stock Option (Right to Buy) | D | 12,57 | 5 144 | 5 144 | |||||
| 2015-05-06 | 2015-05-04 | 4 | SCHELLER RICHARD H | XENE | Stock Option (Right to Buy) | D | 13,48 | 3 086 | 3 086 | |||||
| 2015-05-06 | 2015-05-04 | 4 | AZAB MOHAMMAD | XENE | Stock Option (Right to Buy) | D | 13,48 | 3 086 | 3 086 | |||||
| 2015-05-06 | 2015-05-04 | 4 | Evans Johnston L | XENE | Stock Option (Right to Buy) | D | 13,48 | 3 086 | 3 086 | |||||
| 2015-05-06 | 2015-05-04 | 4 | Hayden Michael R | XENE | Stock Option (Right to Buy) | D | 13,48 | 3 086 | 3 086 | |||||
| 2015-05-06 | 2015-05-04 | 4 | PATOU GARY | XENE | Stock Option (Right to Buy) | D | 13,48 | 3 086 | 3 086 | |||||
| 2015-05-06 | 2015-05-04 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 13,48 | 1 028 | 1 028 | |||||
| 2015-05-06 | 2015-05-04 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 13,48 | 3 086 | 3 086 | |||||
| 2015-05-06 | 2015-05-04 | 4 | HOLLER FRANK A | XENE | Stock Option (Right to Buy) | D | 13,48 | 3 086 | 3 086 | |||||
| 2015-05-04 | 2015-04-30 | 4 | STEIN EVAN A. | XENE | Common Shares | I | 4 172 | 4 172 | ||||||
| 2015-05-04 | 2015-04-30 | 4 | STEIN EVAN A. | XENE | Common Shares | I | 909 619 | 910 586 | ||||||
| 2015-05-04 | 2015-04-30 | 4 | STEIN EVAN A. | XENE | Common Shares | I | −1 038 964 | 0 | ||||||
| 2015-03-19 | 2015-03-17 | 4 | ROBIN SHERRINGTON | XENE | Stock Option (Right to Buy) | D | 17,76 | 35 000 | 35 000 | |||||
| 2015-03-19 | 2015-03-17 | 4 | PIMSTONE SIMON N. | XENE | Stock Option (Right to Buy) | D | 17,76 | 95 000 | 95 000 | |||||
| 2015-03-19 | 2015-03-17 | 4 | MORTIMER IAN | XENE | Stock Option (Right to Buy) | D | 17,76 | 55 000 | 55 000 | |||||
| 2015-03-19 | 2015-03-17 | 4 | GOLDBERG Y. PAUL | XENE | Stock Option (Right to Buy) | D | 17,76 | 35 000 | 35 000 | |||||
| 2015-03-19 | 2015-03-17 | 4 | CORRAINI KAREN G. | XENE | Stock Option (Right to Buy) | D | 17,76 | 35 000 | 35 000 | |||||
| 2015-03-19 | 2015-03-17 | 4 | COHEN CHARLES J. | XENE | Stock Option (Right to Buy) | D | 17,76 | 35 000 | 35 000 | |||||
| 2015-03-18 | 3 | SCHELLER RICHARD H | XENE | No securities are beneficially owned | D | 0 | ||||||||
| 2015-03-18 | 2015-03-16 | 4 | SCHELLER RICHARD H | XENE | Stock Option (Right to Buy) | D | 17,65 | 5 144 | 5 144 | |||||
| 2015-02-05 | 2015-02-03 | 4 | Hayden Michael R By Genworks Inc. | XENE | Stock Option (Right to Buy) | I | 4,81 | −5 144 | 0 | |||||
| 2015-02-05 | 2015-02-03 | 4 | Hayden Michael R By Genworks Inc. | XENE | Common Shares | I | 4,8100 | 5 144 | 25 | 10 288 | ||||
| 2015-01-21 | 2015-01-07 | 4/A | PATOU GARY | XENE | Stock Option (Right to Buy) | D | 4,98 | −3 497 | 0 | |||||
| 2015-01-21 | 2015-01-07 | 4/A | PATOU GARY | XENE | Common Shares | D | 22,2800 | −953 | −21 | 2 544 | ||||
| 2015-01-21 | 2015-01-07 | 4/A | PATOU GARY | XENE | Common Shares | D | 4,9800 | 3 497 | 17 | 3 497 | ||||
| 2015-01-12 | 2015-01-08 | 4 | AZAB MOHAMMAD | XENE | Stock Option (Right to Buy) | D | 4,98 | −2 469 | 0 | |||||
| 2015-01-12 | 2015-01-08 | 4 | AZAB MOHAMMAD | XENE | Common Shares | D | 4,9800 | 2 469 | 12 | 2 469 | ||||
| 2015-01-12 | 2015-01-08 | 4 | Hayden Michael R By Genworks Inc. | XENE | Stock Option (Right to Buy) | I | 4,98 | −5 144 | 0 | |||||
| 2015-01-12 | 2015-01-08 | 4 | Hayden Michael R By Genworks Inc. | XENE | Common Shares | I | 4,9800 | 5 144 | 26 | 5 144 | ||||
| 2015-01-12 | 2015-01-08 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 4,98 | −5 041 | 0 | |||||
| 2015-01-12 | 2015-01-08 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | 4,9800 | 5 041 | 25 | 53 624 | ||||
| 2015-01-09 | 2015-01-07 | 4 | PATOU GARY | XENE | Stock Option (Right to Buy) | D | 4,98 | −3 497 | 0 | |||||
| 2015-01-09 | 2015-01-07 | 4 | PATOU GARY | XENE | Common Shares | D | 4,9800 | 3 497 | 17 | 3 497 | ||||
| 2015-01-07 | 2014-12-31 | 4 | MX Associates, LLP | XENE | Common Shares | D | −17 680 | 0 | ||||||
| 2015-01-07 | 2014-12-31 | 4 | MX Associates, LLP | XENE | Common Shares | D | −85 119 | 17 680 | ||||||
| 2015-01-07 | 2014-12-31 | 4 | MX Associates, LLP | XENE | Common Shares | D | −85 119 | 17 680 | ||||||
| 2015-01-07 | 2014-12-31 | 4 | MX Associates, LLP | XENE | Common Shares | D | −117 456 | 187 918 | ||||||
| 2015-01-07 | 2014-12-31 | 4 | MX Associates, LLP | XENE | Common Shares | D | −1 169 286 | 305 374 | ||||||
| 2014-11-25 | 2014-11-21 | 4 | Bridger Gary | XENE | Stock Option (Right to Buy) | D | 12,65 | 5 144 | 5 144 | |||||
| 2014-11-12 | 2014-11-09 | 4 | HOLLER FRANK A | XENE | Series E Preferred Shares | D | −2 737 | 0 | ||||||
| 2014-11-12 | 2014-11-09 | 4 | HOLLER FRANK A | XENE | Series B Preferred Shares | D | −4 988 | 0 | ||||||
| 2014-11-12 | 2014-11-09 | 4 | HOLLER FRANK A By wife | XENE | Series A Preferred Shares | I | −941 | 0 | ||||||
| 2014-11-12 | 2014-11-09 | 4 | HOLLER FRANK A | XENE | Series A Preferred Shares | D | −95 002 | 0 | ||||||
| 2014-11-12 | 2014-11-09 | 4 | HOLLER FRANK A By wife | XENE | Common Shares | I | 941 | 1 184 | ||||||
| 2014-11-12 | 2014-11-09 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 2 737 | 173 618 | ||||||
| 2014-11-12 | 2014-11-09 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 4 988 | 170 881 | ||||||
| 2014-11-12 | 2014-11-09 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 95 002 | 165 893 | ||||||
| 2014-11-12 | 2014-11-09 | 4 | Evans Johnston L By Invesco Capital Entities | XENE | Series E Preferred Shares | I | −444 655 | 0 | ||||||
| 2014-11-12 | 2014-11-09 | 4 | Evans Johnston L By Invesco Capital Entities | XENE | Common Shares | I | 444 655 | 444 655 | ||||||
| 2014-11-12 | 2014-11-09 | 4 | Hayden Michael R By wife | XENE | Series E Preferred Shares | I | −1 504 | 0 | ||||||
| 2014-11-12 | 2014-11-09 | 4 | Hayden Michael R By wife | XENE | Series B Preferred Shares | I | −2 693 | 0 | ||||||
| 2014-11-12 | 2014-11-09 | 4 | Hayden Michael R By wife | XENE | Series A Preferred Shares | I | −10 030 | 0 | ||||||
| 2014-11-12 | 2014-11-09 | 4 | Hayden Michael R By wife | XENE | Common Shares | I | 1 504 | 75 886 | ||||||
| 2014-11-12 | 2014-11-09 | 4 | Hayden Michael R By wife | XENE | Common Shares | I | 2 693 | 74 382 | ||||||
| 2014-11-12 | 2014-11-09 | 4 | Hayden Michael R By wife | XENE | Common Shares | I | 10 030 | 71 689 | ||||||
| 2014-11-12 | 2014-11-09 | 4 | TARNOW MICHAEL M | XENE | Series A Preferred Shares | D | −16 718 | 0 | ||||||
| 2014-11-12 | 2014-11-09 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | 16 718 | 48 583 | ||||||
| 2014-11-12 | 2014-11-09 | 4 | PIMSTONE SIMON N. | XENE | Series B Preferred Shares | D | −1 914 | 0 | ||||||
| 2014-11-12 | 2014-11-09 | 4 | PIMSTONE SIMON N. | XENE | Series A Preferred Shares | D | −964 | 0 | ||||||
| 2014-11-12 | 2014-11-09 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 1 914 | 192 307 | ||||||
| 2014-11-12 | 2014-11-09 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 964 | 190 393 | ||||||
| 2014-11-12 | 2014-11-09 | 4 | STEIN EVAN A. By Lipoterx, Ltd. | XENE | Series E Preferred Shares | I | −1 038 964 | 0 | ||||||
| 2014-11-12 | 2014-11-09 | 4 | STEIN EVAN A. By Stein Family LLC | XENE | Series B Preferred Shares | I | −967 | 0 | ||||||
| 2014-11-12 | 2014-11-09 | 4 | STEIN EVAN A. By Lipoterx, Ltd. | XENE | Common Shares | I | 1 038 964 | 1 038 964 | ||||||
| 2014-11-12 | 2014-11-09 | 4 | STEIN EVAN A. By Stein Family LLC | XENE | Common Shares | I | 967 | 967 | ||||||
| 2014-11-12 | 2014-11-09 | 4 | MX Associates, LLP | XENE | Series E Preferred Shares | D | −1 474 660 | 0 | ||||||
| 2014-11-12 | 2014-11-09 | 4 | MX Associates, LLP | XENE | Common Shares | D | 1 474 660 | 1 474 660 | ||||||
| 2014-11-06 | 3/A | HOLLER FRANK A By wife | XENE | Common Shares | I | 243 | ||||||||
| 2014-11-06 | 3/A | HOLLER FRANK A | XENE | Common Shares | D | 70 891 | ||||||||
| 2014-11-06 | 2014-11-04 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 9,00 | 5 144 | 5 144 | |||||
| 2014-11-06 | 2014-11-04 | 4 | Hayden Michael R | XENE | Stock Option (Right to Buy) | D | 9,00 | 5 144 | 5 144 | |||||
| 2014-11-06 | 2014-11-04 | 4 | AZAB MOHAMMAD | XENE | Stock Option (Right to Buy) | D | 9,00 | 5 144 | 5 144 | |||||
| 2014-11-06 | 2014-11-04 | 4 | Evans Johnston L | XENE | Stock Option (Right to Buy) | D | 9,00 | 5 144 | 5 144 | |||||
| 2014-11-06 | 2014-11-04 | 4 | PATOU GARY | XENE | Stock Option (Right to Buy) | D | 9,00 | 5 144 | 5 144 | |||||
| 2014-11-06 | 2014-11-04 | 4 | STEIN EVAN A. | XENE | Stock Option (Right to Buy | D | 9,00 | 5 144 | 5 144 | |||||
| 2014-11-06 | 2014-11-04 | 4 | HOLLER FRANK A | XENE | Stock Option (Right to Buy) | D | 9,00 | 5 144 | 5 144 | |||||
| 2014-11-04 | 3 | CORRAINI KAREN G. | XENE | Common Shares | D | 4 114 | ||||||||
| 2014-11-04 | 3 | CORRAINI KAREN G. | XENE | Common Shares | D | 4 114 | ||||||||
| 2014-11-04 | 3 | Hayden Michael R | XENE | Common Shares | D | 256 297 | ||||||||
| 2014-11-04 | 3 | Hayden Michael R By wife | XENE | Common Shares | I | 220 637 | ||||||||
| 2014-11-04 | 3 | Hayden Michael R | XENE | Common Shares | D | 256 297 | ||||||||
| 2014-11-04 | 3 | Hayden Michael R By wife | XENE | Common Shares | I | 220 637 | ||||||||
| 2014-11-04 | 3 | TARNOW MICHAEL M | XENE | Common Shares | D | 63 730 | ||||||||
| 2014-11-04 | 3 | TARNOW MICHAEL M | XENE | Common Shares | D | 63 730 | ||||||||
| 2014-11-04 | 3 | HOLLER FRANK A | XENE | Common Shares | D | 142 025 | ||||||||
| 2014-11-04 | 3 | HOLLER FRANK A By wife | XENE | Common Stock | I | 71 377 | ||||||||
| 2014-11-04 | 3 | HOLLER FRANK A | XENE | Common Shares | D | 142 025 | ||||||||
| 2014-11-04 | 3 | HOLLER FRANK A By wife | XENE | Common Stock | I | 71 377 | ||||||||
| 2014-11-04 | 3 | ROBIN SHERRINGTON | XENE | Common Shares | D | 4 114 | ||||||||
| 2014-11-04 | 3 | ROBIN SHERRINGTON | XENE | Common Shares | D | 4 114 | ||||||||
| 2014-11-04 | 3 | PIMSTONE SIMON N. | XENE | Common Shares | D | 395 318 | ||||||||
| 2014-11-04 | 3 | PIMSTONE SIMON N. | XENE | Common Shares | D | 395 318 | ||||||||
| 2014-11-04 | 3 | PIMSTONE SIMON N. By wife | XENE | Common Shares | I | 222 349 | ||||||||
| 2014-11-04 | 3 | PIMSTONE SIMON N. By wife | XENE | Common Shares | I | 222 349 | ||||||||
| 2014-11-04 | 3 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 8 640 | ||||||||
| 2014-11-04 | 3 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 8 640 |
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
